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Abstract
Background: The nation’s HIV infection rate is alarming, yet only a small percentage of eligible
individuals are prescribed pre-exposure prophylaxis (PrEP). This sluggish PrEP uptake may be
related to lack of knowledge among non-HIV specialist providers. Thus, interventions toexpand
providers’ use of PrEP as an HIV prevention strategy are needed.
Objectives: The project aim was to develop an intervention to improve retail nurse
practitioners’ (NP) knowledge for PrEP clinical practice, comfort screening for “at-risk HIV”
patients, confidence prescribing PrEP, and likeliness to prescribe PrEP in the next six months.
Methodology: An online PrEP tutorial was implemented for retail clinic NPs. There were three
phases: pre-survey, post-survey, and 30-day retention survey. Paired t-tests for differences
between the pre- and post-surveys were performed. ANOVA was conducted to test differences
between pre-, post-, and 30-day retention surveys.
Results: Paired t-tests revealed significant differences between pre- and post-surveys for
knowledge, comfort, confidence, and likeliness to prescribe (p <.05). Similarly, the repeated
measures ANOVA revealed a significant main effect of the intervention on all constructs (p
<.05). Post-hoc analysis showed all constructs, except for comfort, increased betweenthe preand post-surveys and all constructs increased between pre- and retention surveys. There were no
differences between post- and retention surveys for any constructs.
Conclusion: By increasing knowledge related to PrEP, online education can improve NPs
consultation and prescribing practices to help confront the HIV epidemic.
Keywords: PrEP, HIV prevention, online PrEP education, provider knowledge

THE PREP EDUCATION INTERVENTION

3

Table of Contents
The PrEP Education Intervention ................................................................................................... 7
Background and Significance......................................................................................................... 7
Preexposure Prophylactic Therapy ........................................................................................ 8
Purview Paradox and PrEP Affordability .............................................................................. 9
Needs Assessment ........................................................................................................................ 10
Internal Strengths and Weaknesses ...................................................................................... 10
External Opportunities ......................................................................................................... 12
External Threats ................................................................................................................... 13
Problem Statement ....................................................................................................................... 13
PICOT Question ........................................................................................................................... 13
Aims and Objectives .................................................................................................................... 14
Smart Goals .................................................................................................................................. 14
Review of Literature..................................................................................................................... 15
Provider Knowledge of PrEP ............................................................................................... 16
Comfort with Screening for PrEP Eligibility ....................................................................... 18
Confidence with Prescribing PrEP ....................................................................................... 19
Education to Improve PrEP Prescribing .............................................................................. 19
Knowledge Gap .................................................................................................................... 21
Evidence-Based Practice Translation Model ............................................................................... 21
Application of the Iowa Model Revised: Trigger Identification .......................................... 22
Application of the Iowa Model Revised Overview.............................................................. 22
Application of the IMR: Practice Integration and Dissemination of Outcomes .................. 23

THE PREP EDUCATION INTERVENTION

4

Methodology ................................................................................................................................ 23
Research Design ................................................................................................................... 23
Sampling Strategy ................................................................................................................ 24
PrEP Education Intervention ................................................................................................ 26
Project Timeline ................................................................................................................... 27
Survey Instrument ................................................................................................................ 28
Primary Data Analysis ......................................................................................................... 32
Description of the Software ................................................................................................. 33
Needed Resources ................................................................................................................ 33
Results .......................................................................................................................................... 34
Sample Characteristics ......................................................................................................... 34
Pre- vs. Post-Survey Scores ................................................................................................. 35
Post- and Retention Surveys ................................................................................................ 35
Likeliness to Prescribe PrEP ................................................................................................ 37
Discussion .................................................................................................................................... 38
Educational Implications ...................................................................................................... 41
Implications for Practice ...................................................................................................... 42
Implications for Healthcare Policy....................................................................................... 42
Implications for Executive Leadership ................................................................................ 43
Implications for Quality/Safety ............................................................................................ 43
Limitations ........................................................................................................................... 44
Plans for Sustainability ........................................................................................................ 44
Future Direction ................................................................................................................... 44

THE PREP EDUCATION INTERVENTION

5

Conclusion .................................................................................................................................... 45
References .................................................................................................................................... 46
Appendix A SWOT Analysis ....................................................................................................... 54
Appendix B Evidence Table ......................................................................................................... 55
Appendix C Iowa Model Revised ................................................................................................ 67
Appendix D Project Team Members ............................................................................................ 68
Appendix E GWU IRB Determination ........................................................................................ 69
Appendix F Intervention Syllabus ................................................................................................ 70
Appendix G Intervention Methodology Map ............................................................................... 71
Appendix H Intervention Timeline .............................................................................................. 72
Appendix I Informed Consent ...................................................................................................... 74
Appendix J PrEP Education Survey ............................................................................................. 76
Appendix K Variable Table.......................................................................................................... 82
Appendix L Data Dictionary ........................................................................................................ 84
Appendix M Budget Table ......................................................................................................... 110
Appendix N Participant Characteristics and Prior Experiences ................................................ 111
Appendix O Paired t-Test ........................................................................................................... 113
Appendix P Knowledge Mean Scores ........................................................................................ 114
Appendix Q Knowledge Mean, SD, and ANOVA .................................................................... 115
Appendix R Comfort Mean Scores ............................................................................................ 117
Appendix S Comfort Mean, SD, and ANOVA .......................................................................... 118
Appendix T Confidence Mean Scores........................................................................................ 120
Appendix U Confidence Mean, SD, and ANOVA .................................................................... 121

THE PREP EDUCATION INTERVENTION

6

Appendix V All Constructs Mean Scores .................................................................................. 123
Appendix W Likeliness to Prescribe .......................................................................................... 124
Appendix X Friedman’s ANOVA.............................................................................................. 125

THE PREP EDUCATION INTERVENTION

7

The PrEP Education Intervention
According to the Centers for Disease Control and Prevention ([CDC], 2020a), there were
37,832 individuals in 2018 that were newly infected with the human immunodeficiency virus
(HIV), accounting for more than 1.1 million HIV positive Americans. Despite the overall steady
decline that was noted in the past decade, the recent trend of increased HIV diagnoses was most
notable in the South, with 51% of the nation’s new infections (CDC, 2019a). The recently
launched national program, “Ending the HIV Epidemic: A Plan for America,” with its mission to
reduce 75% of HIV infections in the next five years and 90% by the year 2030, is intended to
refuel the national effort to end this epidemic (HIV.gov, 2019). Specifically, the “Plan for
America” is a national movement to decrease new HIV transmissions by increasing the uptake of
the Food and Drug Administration (FDA) approved antiretroviral therapy (ART). Rationales for
the plateaued HIV infection rate included the lack of access, uptake, and adherence to PrEP
(Pinto et al., 2018). Thus, recent studies have carefully examined the existing barriers, including
provider knowledge, comfort, and confidence along with patient access and cost (Clement et al.,
2018; Edelman et al., 2019; Henny et al., 2019b; Pinto et al., 2018) that impact the uptake of
daily pre-exposure prophylaxis (PrEP) for “at-risk HIV” individuals.
Background and Significance
Although the United States had an 11% decline in HIV incidence rates from 2010
through 2017, annual increases in certain groups of the population have recently been detected
(CDC, 2020a). Gay, bisexual, and men having sex with men (MSM) groups of individuals were
most affected, representing 69% of new HIV cases in 2018 (CDC, 2020a). For the same year,
24% of the diagnoses were from heterosexual individuals, and 7% were from injection drug
users (CDC, 2020a).
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Despite the screening strategies and advances with antiretroviral therapies, it was
alarming that the nation’s southern states were disproportionately represented, with almost
20,000 new HIV diagnoses in 2017 (CDC, 2019b). The 16 states and Washington, District of
Columbia (DC) that make up the southern region of the nation, presented with the most
significant burden of HIV and HIV related deaths. Washington, DC had the highest HIV
incidence rate (46.3%), followed by Georgia and Florida, with rates of 24.9% and 22.9%,
respectively (CDC, 2019b). Comparing for the same 2017-year, Virginia Department of Health’s
(2018) HIV incidence rate for Virginia was 10.4% with urban areas like Alexandria and
Arlington counties with 19.4% and 14%, respectively. Many of these infections were notable
among the urban areas. It is worth mentioning, however, that 24% of new diagnoses of HIV in
the southern region in 2017 were reported from suburban and rural areas (CDC, 2019a).
Preexposure Prophylactic Therapy
The combination of tenofovir disoproxil fumarate (TDF) 300 mg and emtricitabine (FTC)
200 mg, which received FDA approval in 2012, was known to be highly effective for prevention
of HIV (CDC, 2019d). As a single daily pill, known as Truvada, the efficacy of PrEP had been
well documented to exceed 92% with consistent usage in multiple studies (CDC, 2019d; U.S.
Preventive Task Force [USPTF], 2019; Zhang et al., 2019). Indeed, the CDC’s 2017 PrEP
Clinical Practice Guideline (CPG; CDC: U.S. Public Health Service, 2018) presented
overwhelming evidence of PrEP’s high efficacy and safety demonstrated through high quality
randomized clinical trials. Additionally, a CDC report predicted that a 40% increased uptake of
PrEP, over ten years, may potentially prevent 33% of new infections among the MSM
subpopulation (Huang et al., 2018).

THE PREP EDUCATION INTERVENTION

9

As reported by the well-known iPrEX clinical trial, the CDC supported the iPrEX
modeling to predict a 99% reduction in the risk of HIV if Truvada was taken every day of the
week (Anderson et al., 2012). Numerous research studies supported the safety and efficacy of the
FDA approved PrEP (CDC: U.S. Public Health Service, 2018; Clement et al., 2018; Henny et al.,
2019; Wilson et al., 2020; Wood et al., 2018; Zhang et al., 2019). Recently, the USPTF (2019)
updated its final recommendation to offer the “A” rating for PrEP, declaring substantial net
benefit of risk reduction for individuals with high HIV risk. Hence, researchers continued to
question why prescriptions for PrEP have been lagging, despite its proven efficacy to reduce the
risk of HIV transmission.
Purview Paradox and PrEP Affordability
Experts identified one of the critical barriers to successful PrEP implementation to be the
“purview paradox.” This notion suggested that neither infectious disease (ID) physicians nor
primary care providers (PCPs) believed PrEP to fall within their specific scope of practice (Pinto
et al., 2018). ID specialists had treated individuals with HIV diagnosis, while PCPs had not been
familiar with HIV-related pharmacotherapy or management. For many years, the debate over
identifying the appropriate providers to prescribe PrEP ensued while addressing the affordability
of Truvada. These factors were previously studied to explain the less-than-optimal PrEP
prescribing patterns (Edelman et al., 2019; Pinto et al., 2018; Zhang et al., 2019).
Although the high cost of Truvada has posed a barrier for those without health plans, the
“Patient Assistance” program through the Gilead pharmaceutical company was available for
many years (Gilead, 2020a). Moreover, the USPTF recently updated its PrEP recommendation to
reflect patients’ cost-sharing to zero copayments for the insured individuals. This change
mirrored the Affordable Care Act’s requirement that preventive medicine with USPTF’s “A” or
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“B” rating must be covered for patients without any cost-sharing (Keith, 2019). While exploring
the “purview paradox” among PCPs, researchers simultaneously uncovered themes such as lack
of knowledge and comfort among non-HIV specialized health care providers (Blackstock et al.,
2016; Edelman et al., 2019; Hakre et al., 2016; Petroll et al., 2017; Wood et al., 2018b; Zhang et
al., 2019).
Needs Assessment
The CDC’s HIV prevention efforts endorsed by the federal government supported
expanding the access and uptake of PrEP, especially in the rural and suburban communities of
the southern United States (US; CDC, 2019a). To collaborate in this national effort, frontline
providers that are not HIV specialists had to become the new champions to improve PrEP uptake
for those individuals at risk for HIV. Retail clinics, ideally positioned in communities, employed
frontline providers that can commit to reducing new HIV infections. Numerous researchers have
supported the need for non-HIV specialists to improve their knowledge of PrEP, comfort to
screen for at-risk HIV candidates, and confidence to prescribe PrEP therapy (Edelman et al.,
2019; Henny et al., 2019a; Henny et al., 2019b; Wilson, 2020).
To further evaluate the needs for this quality improvement project, it was essential to
evaluate the strengths, weaknesses, opportunities, and threats related to the organization and the
topic of PrEP educational needs. The strengths, weaknesses, opportunities, and threats (SWOT)
associated with the current project were analyzed (see Appendix A).
Internal Strengths and Weaknesses
A needs assessment was conducted for a retail clinic organization located in the southern
region of the US to assess the need for an education intervention. With its mission statement,
“helping people on their path to better health,” the retail clinics of Northern Virginia and
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Washington, DC are recognized for healthcare convenience and quality (Anonymous, 2020). The
organization’s values of “innovation, collaboration, caring, integrity, and accountability” were
embedded in the quality services delivered seven days a week by dedicated nurse practitioners
(NP) throughout the two regions (R22 and R23) (Anonymous, 2020). A significant strength of
the organization was that most NPs were professionally committed and engaged in continuous
educational opportunities to advance their knowledge and expertise.
Another strength was the organization highly valued the Doctor of Nursing Practice
(DNP) degree and supported DNP projects. Many changes to the current workflow were a result
of past DNP projects conducted within the organization. Moreover, the chief executive officer
(CEO) was a DNP leader who practiced engaging leadership.
The major advantage of the project was the retail clinic organization’s commitment to
innovative services while adhering to evidence-based practice (EBP) guidelines. The retail
clinics also offered a variety of services, from minor episodic illnesses to routine health
screenings that include screenings for sexually transmitted infections (STI). Most recently, a
“Health Hub” theme was launched to offer more in-depth chronic care management and “young
adult health” services. The Health Hub concept includes phlebotomy services that are needed for
the full array of STI screening visits. Patients could conveniently get their blood work done in
one setting instead of having to get to laboratory facilities. Thus, the internal strengths of the
retail clinics presented the fuel to drive a PrEP education intervention towards improving
provider knowledge that may ultimately delineate delivery of quality care.
The organization was well-structured with many layers of company oversight, which
presented some challenges for a DNP student-led initiative. With its national branding well
known to the public, the retail health clinic organization did not permit the use of any patient
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data. This included de-identified, aggregate patient data, as well as heavily secured clinical
practice guidelines. As a highly innovative organization, new updates were occurring every week
that impacted the planned PrEP education intervention’s timeline. Another weakness was the
busy clinic setting that restricted the solo practitioner from becoming adequately engaged with
learning activities in between patient visits. Newly graduated NPs with less than one year of
experience faced more challenges of being inundated with overwhelming learning activities.
Finally, retail clinics were not affiliated with infectious disease specialists and did not have
relationships with these specialists. NPs, however, had collaborative medical directors they
consulted when they needed further medical advice and guideline support. Despite these
obstacles, the senior practice managers (SPM) for the Northern Virginia and Washington, DC
regions fully endorsed this student-led PrEP education intervention.
External Opportunities
The current HIV epidemic has captivated the attention of the Federal and State
government. Released in 2019, the federal project “Ending the HIV Epidemic: A Plan for
America,” was a blueprint for reducing new HIV infections by 75% in the next five years and
over 90% for the next ten years (HIV.gov, 2019). This national movement has influenced more
frontline healthcare providers to reflect on their knowledge regarding HIV infections, comfort in
screening patients for PrEP, and confidence in prescribing PrEP. After losing its coveted patent,
the generic version of Truvada became available last year (Fitzsimons, 2019). Equally important,
the retail clinics were noted as “PrEP Providers” through the CDC’s (2020b) “PrEP Provider”
database link. Despite this title, PrEP service was underutilized in light of the concerning STI
infection rates for the region. With metropolitan DC’s alarming HIV incidence rate, retail clinics
in this region were perfectly positioned to join the national efforts to reduce the transmission of
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HIV.
External Threats
The Health Hub concept consists of chronic disease management and a broader scope of
young adult health services. The individuals that are “at-risk” for HIV often encounter barriers
such as medical stigma, medical mistrust and perceived payment barriers that prevent them from
receiving STI preventive services. Many uninsured individuals will be challenged to seek PrEP
therapy due to the ongoing need for clinic follow-ups. If the Health Hub transformation failed for
any reason, NPs would not have the opportunity to provide young adult health needs and
screenings. Thus, the PrEP education intervention’s long-term desired outcomes will not be
notable if clinics were faced with conditions that limited patient visit volume or unprecedented
clinic closures. Despite these potential threats, the organization supported the current student-led
PrEP training initiative as a pilot study for both Regions 22 and 23 that represent Washington
DC and Northern Virginia.
Problem Statement
About 80% of HIV infections in 2016 were transmitted by individuals who were
undiagnosed with HIV and not receiving HIV care (HIV.gov, 2019). Although more than one
million Americans may potentially benefit from PrEP, fewer than 25% of them have been
prescribed HIV prevention therapy (CDC, 2020c). As frontline providers, the retail health clinic
nurse practitioners (NPs) must have knowledge to provide PrEP screening, appropriate
treatment, and precise management for at-risk HIV individuals of the community.
PICOT Question
For retail health nurse practitioners, how does PrEP education/training affect providers’
knowledge about PrEP clinical practice, comfort with screening, and confidence prescribing
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PrEP for “at-risk HIV” individuals after the intervention period?
Aims and Objectives
The following aims were pertinent for the PrEP Education Intervention:
1) Evaluate NPs’ pre-intervention baseline composite scores and ratings on all constructs
including clinical practice knowledge about PrEP, comfort identifying “at- risk HIV”
patients, confidence with PrEP prescribing practices, and likeliness to prescribe PrEP in
the next six months.
2) Implement an online education module on PrEP clinical practice knowledge, screening
for “at-risk HIV” candidates, and PrEP prescribing practices.
3) Evaluate NPs’ post-intervention composite scores and ratings on all constructs.
4) Evaluate differences between NPs’ pre- and post-intervention composite scores and
ratings on all constructs.
5) Thirty days after completion of the PrEP education, reevaluate NPs’ composite scores
and ratings on all constructs and compare with pre and post intervention scores and
ratings.
Smart Goals
These sound goals provided direction, motivation, and a clear focus for the project
implementation. The following were “SMART” goals that were specific, measurable, achievable,
realistic, and timely.
1) Develop and implement an online PrEP education module by July 24, 2020.
2) Obtain NP’s baseline and post-intervention composite scores (constructs of knowledge,
comfort, confidence, and likeliness to prescribe PrEP in the next six months) by
September 26, 2020.

THE PREP EDUCATION INTERVENTION

15

3) Post-survey PrEP’s composite scores and ratings on all constructs (clinical practice
knowledge, comfort identifying at-risk HIV patients, confidence prescribing PrEP, and
likeliness to prescribe PrEP within the next six months) will be improved from their
baseline pre-survey scores following the education intervention and by the closure date of
the post-survey period of September 26, 2020.
4) Composite scores and ratings on all constructs for knowledge, comfort, confidence, and
likeliness to prescribe PrEP will be retained with less than 5% loss at the 30 days postintervention completion date of November 7, 2020.
Review of Literature
A comprehensive literature review unveiled gaps regarding lack of knowledge, comfort,
and confidence with clinical PrEP practice among non-HIV specialist healthcare providers.
Evidence pointed to the positive value of delivering an education intervention to improve nonHIV specialist healthcare providers’ knowledge related to these constructs. An evidence table
summarizing the information related to each reviewed source is included as Appendix B.
Construct Definitions
Although the term “knowledge” is relatively clear, construct descriptions like “comfort,”
“confidence” and “willingness” need clarification. The phrase, “knowledge about PrEP” was
also noted in the literature review as the “familiarity” or “awareness” about PrEP
pharmacotherapy and/or its prescribing practice guidelines (Edelman et al., 2019; Petroll et al.,
2017; Wilson et al., 2020; Wood et al., 2018b; Zhang et al., 2019). Additionally, words such as
comfort, confidence, and willingness were used in numerous research studies that were
evaluating the suboptimal uptake of PrEP (Edelman et al., 2019; Petroll et al., 2017; Wilson et
al., 2020). For this purpose, this quality improvement project focused on the definitions reflected
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in the online English dictionary. First, “confidence” as a noun describes the “belief in oneself
and abilities” (Dictionary.com, 2021a, para 2). Next, the word “comfort” as a verb is described
as, “to soothe, console or to reassure” (Dictionary.com, 2021b, para 1) while the verb usage as
“comfortable” is defined as the physical and mental state of contentment and being “at ease”
(Dictionary.com, 2021c, para 2). Since the word “willingness” can suggest consent or readiness
and the preference to decide on one’s actions, it is important not to conflate comfort and
willingness to prescribe PrEP since these are different constructs (Dictionary.com, 2021d).
Provider Knowledge of PrEP
Edelman et al.’s (2019) survey revealed that 85% of 240 general internists surveyed
believed that PrEP practice should be integrated within the primary care setting instead of
making referrals to specialists. To accomplish the integration of PrEP into clinical practice, most
of the providers believed in training all providers at the practice site (42%) or employing an
onsite PrEP provider (43%). Most of the surveyed providers in favor of enhancing their PrEP
knowledge were practitioners who performed direct patient care (Edelman et al., 2019). The
concept of the knowledge gap among non-HIV specialist providers has been explored in
numerous articles. The term “knowledge” was broadened to include awareness or familiarity
about PrEP, as well as the clinical concepts that support the management of PrEP therapy.
Wilson et al. (2020) examined the poor uptake of PrEP for the US Navy despite Truvada’s
availability at no cost. Out of the 432 Navy providers participating in the survey, most rated their
knowledge as “poor” (41%) or “sufficient” (31%), compared to 17.1% who rated their
knowledge as “good” or “excellent” (6.9%) (Wilson et al., 2020). Among providers that selfidentified as being knowledgeable about PrEP, 29% were found to prescribe PrEP more often
compared to those providers with poor knowledge ratings (6%) (Wilson et al., 2020). It is not

THE PREP EDUCATION INTERVENTION

17

surprising that only 19% of Navy providers reported ever prescribing PrEP (Wilson et al., 2020).
Similarly, Henny et al. (2019b) conducted the “K-Bap Study” that explored HIV-related
knowledge, behaviors, attitudes, and practices among providers in the southeast part of the
country. The online survey of 820 PCPs revealed that more than 52% of the providers lacked
familiarity with PrEP (2019b). Arising from the potential side effect profile, insufficient PrEP
knowledge can predict hesitancy to prescribe even to eligible patients meeting the screening
criteria. A recent meta-analysis conducted by Zhang et al. (2019) examined healthcare
professionals’ obstacles that blocked the optimal PrEP implementation. Aside from PrEP’s cost,
safety, and side effect that were identified as barriers, providers’ lack of awareness, knowledge,
skills, and lack of training were found to impact PrEP provision among healthcare professionals
(Zhang et al., 2019). The pooled proportion of PCP with awareness of PrEP was 68% (95% CI
55-80%), and the rate of prescribing PrEP was 24% (95% CI=17-32%) (Zhang et al., 2019).
These studies revealed the knowledge gap that exists among frontline PCPs and other healthcare
professionals regarding PrEP prescribing practices.
Several studies revealed providers’ lack of knowledge as a barrier to prescribing PrEP.
Clement et al. (2018) found that 60% of the Duke Health System’s PCPs, before the in-person
education intervention, answered “lack of knowledge” as the reason for not having prescribed
PrEP. Similarly, Irungu et al. (2019) found a lack of knowledge of ART and PrEP eligibility,
indications, benefits, and side effects among Kenyan healthcare workers. Researchers found
improved knowledge and confidence after presenting the two-day interactive training called,
“Partners Scale-Up Project” for the public health facilities in Kenya (Irungu et al., 2019). The
pre intervention’s mean score of 61.7% suggested a lack of knowledge among various healthcare
workers (Irungu et al., 2019). Moreover, Newman et al. (2018) conducted an educational
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intervention for medical residents and found that 22% of the 45 residents surveyed were not at all
familiar with PrEP before the education session.
Comfort with Screening for PrEP Eligibility
Providers’ prescribing practices depend on knowledge of the drug and understanding the
patients’ ultimate benefit from pharmacotherapy options. Specifically, providers need to assess
the PrEP eligibility with patients through the sensitive discussion of patients’ sexual practices.
Few studies have used the term “comfort” to address providers’ attitudes about being engaged
with PrEP practice and sensitive patient discussions (Clement et al., 2018; Irungu et al., 2019;
Newman et al., 2019; Wilson et al., 2020). Newman et al. (2019) found that providers’ comfort
in assessing clinical eligibility across different clinical situations did not improve after their PrEP
training session. Pre- and post-training results for comfort with assessing clinical PrEP
eligibility, which included sexual risk categories, were not statistically significant. However,
“comfort” with prescribing PrEP increased among the medical students, who had a preintervention score of 35% compared with the post-intervention score of 70% (p = .015)
(Newman et al., 2019). Irungu et al. (2019) found that 30% of providers initially reported feeling
“very uncomfortable” and “unsure” before the PrEP training for serodiscordant couples of
Kenya. Likewise, Clement al. (2018) found 42% of PCPs, that had never prescribed Truvada,
indicated “lack of comfort” as the reason for not ever prescribing PrEP. Not surprisingly, Wilson
et al. (2020) found that Navy providers who were most comfortable assessing patients’ sexual
risk behaviors had increased knowledge about PrEP. Although these studies collectively
suggested an unclear relationship between knowledge of PrEP, comfort in assessing patient risk
behaviors, and PrEP prescribing practices, the results suggested that training improved
providers’ comfort with screening for “at-risk HIV” behaviors and prescribing PrEP.
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Confidence with Prescribing PrEP
With an unclear picture of how knowledge influenced likeliness to prescribe PrEP and
the role of comfort in assessing patient risk behaviors, it was worth exploring how education may
improve provider confidence managing and prescribing PrEP therapy. The confidence to
prescribe Truvada and manage patients on PrEP therapy stemmed from providers’ PrEP
knowledge and prior experience (Mayer et al., 2018). Several studies revealed that providers
were not initially confident with Truvada’s safety, effectiveness, and prescribing practices due to
lack of awareness of the clinical PrEP guideline (Henny et al., 2019a; Newman et al., 2019;
Wilson et al., 2020). For this purpose, numerous studies and PrEP experts emphasized the need
for frontline providers to participate in PrEP educational or training sessions (Clement et al.,
2018; Henny et al., 2019b; Wilson et al., 2020; Wood et al., 2018b; Zhang et al., 2019). Based on
the research, it was important to establish whether educating healthcare providers about PrEP
improved knowledge in prescribing PrEP therapy.
In short, many studies explored the provider barriers that can be addressed through
increased education. The literature review uncovered a variety of PrEP related education
interventions ranging from 20–60-minute presentation to weeks of ongoing support. In fact,
Henny et al.’s (2019b) study highlighted the correlation between HIV-related training and
familiarity with PrEP practice which in turn increased prescribing of PrEP. Focused provider
training on PrEP implementation may improve knowledge, comfort, and confidence to improve
their likeliness to prescribe PrEP therapy (Zhang et al., 2019).
Education to Improve PrEP Prescribing
Five recent quasi-experimental studies were systematically reviewed and assessed for
evidence and quality. These studies evaluated whether educational interventions improved
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provider knowledge, comfort assessing patient risk, confidence with PrEP therapy management,
and the likelihood of providers to prescribe this pre-exposure antiretroviral therapy. Most studies
resulted in notable improvements in PrEP knowledge following educational intervention(s)
(Clement et al., 2018; Irungu et al., 2019; Newman et al., 2019; Sales et al., 2019; Wood et al.,
2018b).
Wood et al. (2018b) found that incorporating PrEP telementoring support into an existing
HIV project was feasible and beneficial for providers. More than 93% of the surveyed providers
reported that knowledge topics for PrEP practice, such as pharmacologic side effects, candidacy,
and adherence issues, were covered “extremely” or “moderately” well (Wood et al., 2018b). As a
secondary analysis, Sales et al. (2019) found that 28 providers and staff from family planning
clinics gained higher PrEP knowledge after a 1.5-hour training session (with a pre mean value of
3.26 and post-mean-value of 5.13, p<.001). Newman et al. (2019) also found increased
knowledge among medical residents who participated in a PrEP education intervention, with the
average posttest knowledge score of 92% compared to the pretest score of 66%. Likewise,
Irungu et al. (2019) demonstrated an improvement of knowledge after a two-day training
intervention with a significant gain in the posttest mean score (62% on pretest versus 86.4% on
posttest).
In addition to knowledge improvement, Irungu et al. (2019) found that providers gained
“comfort” treating HIV serodiscordant couples after the educational intervention (22.8% to
67.3%, p<.001). Besides the quantitative approach used to measure an increase in comfort
following an educational intervention, Irungu qualitatively measured the providers’ experience
with the intervention and found that many participants reported “improved confidence” during
post-intervention interviews. Similarly, in addition to improving PrEP knowledge, Sales et al.
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(2019) found providers were more comfortable in their ability to identify appropriate candidates
for daily Truvada therapy. The increase in knowledge, comfort, and confidence found in the
literature also seemed to influence providers’ likeliness to prescribe PrEP. For instance, Newman
et al. (2019) noted an hour-long education intervention improved the subjects’ likeliness to
prescribe PrEP within the next six months from 32% (pretest) to 67% (posttest). Finally, Clement
et al. (2018) demonstrated that after an educational intervention, providers prescribed PrEP to
35% of eligible patients, as compared to only 17% of patients before the intervention (with a
statistical significance of < .01). Overall, the literature revealed that educational/training
interventions can improve provider knowledge, comfort in assessing for PrEP candidacy,
confidence in PrEP therapy, and likeliness to prescribe PrEP in the future.
Knowledge Gap
Education interventions, varying from one hour to two days in duration, were noted to
reveal improved knowledge for a variety of providers. Specifically, the knowledge gap amongst
the PCPs of the southeast region identified through the “K-Bap” survey underscored the need to
strengthen HIV-related knowledge and practice guidelines for physicians, NPs and physician
assistants (Henny et al. 2019b). This was especially alarming since the highest burden of HIV
prevalence existed in the southern part of the nation. Numerous research findings consistently
supported various forms of HIV-related training to improve the sluggish uptake of PrEP for those
“at-risk” for HIV transmission.
Evidence-Based Practice Translation Model
Developed by the Iowa Model Collaborative group, the Iowa Model Revised: EvidenceBased Practice to Promote Excellence in Health Care Process (IMR) was applied to guide the
PrEP Education Intervention. The path to solving the clinical problem included decision markers
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with evaluation stages that acted as feedback loops with appropriate recommendations during the
practice change implementation process (Buckwalter et al., 2017). The IMR’s essential phases
were as follows: identifying triggering issues, forming the interprofessional team, reviewing the
evidence, accomplishing critique and synthesis of the evidence, piloting the implementation,
integration of practice changes, and dissemination of outcomes (Iowa Model Collaborative,
2017).
Application of the Iowa Model Revised: Trigger Identification
The nation’s capital, Washington, DC has one of the highest HIV incidence rates in the
country. Individuals qualifying to receive PrEP therapy are likely to visit retail health clinics for
minor episodic illnesses or routine screening needs. NPs’ knowledge gap pertaining to PrEP was
identified as a reason to conduct this project. Regardless of the NPs’ inadequate PrEP clinical
knowledge or experience, the retail clinics were already identified as “PrEP Providers” for the
Washington DC metropolitan region (CDC, 2020b). Namely, PrEP encounters included
screening those at high risk for HIV, as well as prescribing the daily therapy available on the
market today. As an innovative organization, the retail health clinic organization approved the
EBP initiative that was directed at improving PrEP knowledge, comfort, and prescribing
practices for the NP providers. The Iowa Model Revised (IMR), depicted in a concise flow
diagram (Appendix C), was used to describe the step-by-step process in implementing the PrEP
education initiative.
Application of the Iowa Model Revised Overview
1) Established a problem-focused trigger that created the PICOT statement.
2) Formed a team from the stakeholder group (Table 1).
3) Performed a literature review and synthesis and established the urgency for PrEP
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education interventions.
4) Designed and developed an online, evidence-based PrEP education tutorial and utilized
an evidence-based tool.
5) Implemented the Pilot PrEP Education Intervention for Regions 22 and 23.
6) Evaluated the Pilot Intervention’s pre and post surveys for improved survey scores.
7) Administered post-intervention 30-day retention survey.
8) Reevaluated survey results that include the 30-day retention survey scores.
9) Raffled away gift cards for those that completed all three phases of the survey.
10) Disseminated outcomes with results to the organization.
Application of the IMR: Practice Integration and Dissemination of Outcomes
After completion of the 30-day retention survey, the goal was to record and disseminate
the quality improvement project outcomes throughout the organization’s two regions. The
success of the intervention was shared with the regional quality representatives. The PrEP
Education Intervention did receive approval to be posted in the organization’s intranet site to
encourage completion of this learning opportunity for all providers in the organization.
Methodology
Research Design
The PrEP Education Intervention was an online quality improvement project that aimed
to improve provider knowledge, comfort and confidence regarding screening for patients that are
at-risk for human immunodeficiency virus (HIV) and prescribing PrEP. The project evaluated
providers’ knowledge of PrEP clinical practice, comfort in screening “at-risk HIV” patients, and
confidence in prescribing PrEP before and after an online educational tutorial. The online
delivery of the educational intervention allowed busy practicing providers to obtain the needed
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education on-demand, rather than trying to coordinate an in-person didactic session suitable for
their schedules. The design of the study was a pre and post-test design in which participants first
received a survey of their baseline PrEP clinical practice knowledge, comfort in screening for
PrEP candidacy, and confidence in prescribing PrEP for “at-risk HIV” individuals (Price et al.,
2015). Following the online educational intervention, the participants received a survey
immediately post-training to measure their learning, comfort, and confidence related to clinical
PrEP practice. It was essential to ensure that improvements in prescriber knowledge, comfort,
and confidence were retained over time. After 30 days, participants received a follow-up survey
to measure long-term knowledge retention, comfort, and confidence in PrEP clinical practice and
prescribing. The surveys also measured the providers’ likeliness to prescribe PrEP in the next
six-month period.
Sampling Strategy
The target population for this initiative was health care providers (i.e., nurse
practitioners) who were employed for a large retail health clinic organization throughout
Northern Virginia (NoVA) and Washington DC. All eligible participants were contacted during
recruitment. The sample, therefore, represented a convenience sample of family practice NPs in
the target region.
Inclusion/Exclusion Criteria
All clinical nurse practitioners, who were full time, part-time, and committed casual parttime staff for the two regions, were eligible to participate in the learning session. Any NP with
anticipated departure from the organization within three weeks of the survey launch date was
excluded from participation.
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Setting and Study Considerations
All parts of the survey were delivered in a remote fashion. The study included online
surveys and an online educational tutorial that were sent via emails. Participation took place
during providers’ “down time” or during break times. Participants were able to complete the
session anywhere they had internet and computer access and were able to pause and resume the
tutorial at any time. The organization’s official support was received from the DNP Project
Committee on July 3rd, 2020.
This project received an approval from the Institutional Review Board of the George
Washington University Ethics Committee on July 15th, 2020 (see Appendix E). As a QI project,
there was no risk of harm to the subjects participating in the PrEP educational activity. All
demographic information and survey responses were kept confidential and only available for the
study’s investigators until the end of December 2023.
Recruitment Strategy
Participant recruitment was elicited through emails. Also, senior practice managers
(SPM) for the two regions, through the daily morning huddles, encouraged their regions’ NPs to
participate. Pre-intervention emails (Email #1) were sent to participants on multiple dates one
week before the project launch date to explain and recruit participation for the upcoming study.
This first email before the project launch date was directed at increasing awareness of the
upcoming educational session. The e-mail contained the project syllabus and was sent to all NPs’
work email at least two times during the first week. The syllabus included the learning
objectives, length of training, the purpose of the education session, and appropriate contact
information (See Appendix F). At the initiation of the project launch phase, participants were
sent the “Pre-survey” emails (Email #2) to participate in the study with a web link to complete
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the pre-survey. The pre-survey was launched during weeks two and three. This email included
the link for the pre-survey and was sent at least two times weekly to ensure that NPs were able to
access the weblink in a timely fashion despite job demands. During weeks four through six,
“Education Intervention” emails (Email #3) containing the pre-survey, PrEP tutorial link and the
post-survey were sent to invite participants to complete the intervention training. In an attempt to
recruit additional participants, “Education Intervention” emails were sent out three times during
week nine. This email presented a link that allowed the participants to advance to the
intervention only if they had already completed a presurvey. Four weeks after the closure of the
education training, the final “retention survey” emails (Email #4) were sent during weeks
fourteen and fifteen. As an added incentive, five $20 Target gift certificates were raffled off for
participants who completed the entire PrEP Education Initiative, including the pre- and postsurvey, and 30-day retention survey. An overview of the completed recruitment strategy and data
collection sequence can be found in the figure methodology map (Figure 2).
Sample Size
There were approximately 110 NPs that covered more than 42 retail clinics for the two
regions across Northern Virginia and Washington, DC. The appropriate sample size needed for
this study was determined by estimating the effect size necessary for adequate power using
Cohen’s d sample size conversion. A sample size of 27 was needed for a “moderate” effect size
of .50 and a power of 0.80 in order to conduct a repeated-measures ANOVA with a significance
level of 0.05 (Sullivan & Feinn, 2012). For possible sample size attrition factors, an additional
15% was considered for a total sample size of 31.
PrEP Education Intervention
The link to the education intervention included an “intro video” that introduced pertinent
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background information about the current HIV epidemic and the nation’s mission to improve
PrEP uptake. The six-minute video was an optional background prelude to the PrEP tutorial.
The PrEP for HIV Prevention e-learning tutorial was developed from the CDC’s latest clinical
guidelines on pre-exposure prophylaxis, identifying indications for PrEP, and the current
evidence-based practice and PrEP therapy management. The five topics were as follows: “About
PrEP,” “PrEP Candidacy,” “PrEP Eligibility,” “PrEP Prescriptions,” and “Practice Scenarios.”
The e-learning tutorial was designed to be engaging and interactive that allowed feedback for the
chosen answers. The case scenarios promoted self-directed e-learning through making decisions
based on the case presentations (Moore, 2021). The latest FDA-approved PrEP agent, Descovy,
was also included to educate NPs on all pharmacologic agents available on the market (Gilead,
2020b). Upon completing the tutorial, participants were directed to complete the post-survey.
Project Timeline
The total duration of the PrEP Education Intervention was sixteen weeks long. Table 2
lists detailed weekly activities of the QI project. While waiting for the organizational approval,
the Principal Student Investigator (PSI) developed the online PrEP educational tutorial. The final
consent to launch this DNP project from the Retail Health Clinic’s DNP Project Committee was
received on July 3rd, 2019. Next, the DNP Project Proposal received approval from the George
Washington Institutional Review Board Committee on July 15, 2019. Shortly after receiving the
approvals, preparation was made to launch the project with support from the two regions’ senior
practice managers (SPM). On July 27th, the project started with one week of “pre-intervention”
emails that described the intent of the study. For the next several weeks, emails were sent
routinely to elicit interest and participation. The study ended with the closure of the retention
survey and list of the ten raffle winners.
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Survey Instrument
The PrEP Education Intervention included a survey instrument that was delivered in three
phases: pre-survey, post-survey and retention survey. This survey tool was compiled from a
combination of validated, previously used, and tested survey questions that were developed by
expert researchers. A total of 21 items were taken from an existing survey instrument called PCP
PrEP Survey that had been refined and piloted from an already existing Integrated
Buprenorphine and HIV Care Evaluation (BHIVES) survey (Blackstock et al., 2016; Edelman et
al., 2019; Edelman et al., 2017).
The original 57-item survey that was pilot-tested in an iterative manner by the authors
was used as an online survey to the members of the Society of General Internal Medicine
(SGIM). The PCP PrEP Survey conducted for this national professional organization’s academic
general internists contained provider sociodemographic, practice characteristics, self-rated
knowledge, attitudes, and beliefs about PrEP and PrEP practice adoption (Blackstock et al.,
2016). Consent was obtained to adapt the PCP PrEP Survey items from the principal investigator
on March 28, 2020. Furthermore, Blumenthal et al.’s (2015) five-question PrEP Knowledge
Survey that was modified from the Fenway Institute’s previously utilized instrument was
reviewed. Blumenthal et al. (2015) did mention its weak internal consistency (alpha score of
0.22) due to having only five questions and containing specific questions about various past
clinical trials. Due to the current research advancements with PrEP, only two of the knowledgebased questions from Blumenthal et al. (2015) applied to the current PrEP survey. Upon
requesting the use of this survey instrument, an email with the investigator’s permission was
received on April 3, 2020. Additionally, five questions were developed from the 2017 CDC’s
PrEP Clinical Guideline and recently updated CDC’s PrEP website (CDC, 2019d).
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Consent and Survey Content
A simple information sheet explaining the project and consent process was attached to
every email and available for all prospective participants (Appendix I). Advancing to the presurvey link was synonymous with consent to participate in the study. This project’s survey tool
contained a total of 23 survey items that were compiled from the existing survey instruments and
five items from the CDC’s PrEP clinical practice guideline (see Appendix J). Along with the
necessary items pertaining to demographics and prior experiences, the survey tool presented with
23 questions about the constructs of PrEP clinical practice knowledge, comfort, and confidence
as well as providers’ likeliness to prescribe PrEP in the next six months.
Demographics and Past Experience
The survey instrument started with basic demographic questions that included the
subjects’ prior experiences. The five demographic questions pertained to the following: age,
years of experience as NP; race/ethnicity; education level; and gender. The next five questions,
related to the subjects’ prior experience with PrEP, earned categorical responses of “yes” or “no”
as well as one 5-point Likert scale that expressed the NPs prior knowledge. These five questions
were intended to understand the subjects’ previous experience and one self-rated item about
PrEP’s potential side effects.
The “Knowledge” Construct
The knowledge questions were designed to test the basic PrEP clinical practice that had
been standardized through the CDC’s PrEP clinical guideline. There were three multiple-choice
items included in the survey adopted from the existing PCP PrEP Survey with Likert-type
choices to measure the providers’ perception based on her/his knowledge of the effectiveness
and safety of PrEP. The 4-point Likert Scale consisted of 1= “not at all,” 2 = “slightly,” 3 =
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moderately,” and 4 = “extremely.” Only two items with multiple choice answers from
Blumenthal’s PrEP Survey were used. Five questions with multiple choice answers were
developed from the CDC’s clinical practice guideline. Knowledge related to these items was
explained and reinforced in the online PrEP tutorial. All items received “1-point” for the correct
answer for the maximum cumulative value of 10 points. An increased knowledge score between
baseline (pre-survey) and post-intervention demonstrated improvement in knowledge. This
section was intended to measure the pertinent knowledge regarding PrEP’s clinical practice
endorsed by the CDC clinical guideline and its continuously updated website.
The “Comfort” Construct
While knowledge about clinical PrEP practice was an essential component, assessing
provider comfort to screen the clinical eligibility for daily PrEP was also important. Thus, the
PrEP Education project evaluated if the education intervention improved providers’ comfort in
identifying patients with “at-risk” HIV behaviors that were eligible for PrEP therapy by
comparing changes in pre- and post-intervention comfort ratings. Data for the comfort construct
was collected using the pre-, post- and follow-up surveys distributed to the providers. The choice
of answers was presented in a 4- point Likert Scale to accurately assess provider comfort levels
before and after the educational intervention. A maximum of 16 points for comfort-related
answers represented the provider’s comfort level as “extremely comfortable” in identifying the
various high “at-risk HIV” individuals. At the same time, a total of four points indicated “not at
all comfortable” at identifying “at-risk HIV” individuals for the various risk behavior categories.
Specifically, the 4-point Likert scale descriptions were as follows: 1 = “not at all comfortable”; 2
= “slightly comfortable”; 3 =” moderately comfortable”; 4 =” extremely comfortable.”
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The “Confidence” Construct
The self-confidence concept was a cumulative notion of “believing in oneself” and
certainty that occurs with knowledge and experience (Dictionary.com, 2021a, para 2). Thus, the
working definition for the confidence construct was the confidence to prescribe PrEP that can be
attained with learned knowledge of the current clinical practice guideline that included the safety
profile, side effects, and lab monitoring essentials related to the antiretroviral treatment. The
original PCP PrEP Survey’s questions used the word “willingness” to prescribe PrEP, and these
questions were modified to say, “confidence” to prescribe. When Blackstock et al. (2016)
surveyed the academic general internists in 2015, the adoption of PrEP practice among PCPs was
a relatively novel idea. The authors used the terms “comfort and willingness” to ascertain PCPs’
attitudes and beliefs associated with PrEP practice adoption (Blackstock et al., 2016).
Historically, “willingness to prescribe” was measured when PrEP was a new therapy with limited
guidance for non-HIV prescribing providers. Current evidence-based guidelines recommend
PrEP as a standard of care, so it was more appropriate to assess “confidence” instead of
“willingness” to prescribe.
This QI project evaluated if the education intervention improved providers’ confidence in
prescribing PrEP by comparing providers’ pre- and post-intervention confidence ratings. Data for
the confidence construct were collected using the pre-, post- and 30-day follow-up surveys
distributed to the retail clinic providers. A 4-point Likert scale was used to assess the level of
providers’ confidence to prescribe PrEP based on information known about patients’ sexual
behaviors and drug use. In other words, the eight questions explored the NP providers’ self-rated
ability to identify those “at-risk HIV” patients that would benefit from the daily PrEP therapy as
well as having the confidence about PrEP’s pharmacology profile. A maximum of 32 points
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indicated “extremely confident” rating versus eight points that revealed “not at all confident”
with PrEP prescribing patterns and clinical practice. The confidence to prescribe PrEP for the
“at-risk HIV” patients symbolized NPs’ confidence with the overall management and prescribing
of PrEP therapy. Provider confidence scores were measured as a total composite score.
Likeliness to Prescribe PrEP in Six Months
This QI project evaluated if the education intervention improved the providers’ likeliness
to prescribe PrEP by comparing baseline and post-intervention likeliness to prescribe PrEP. Data
for likeliness to prescribe PrEP were collected using the pre-, post- and follow-up surveys
distributed to the retail clinic providers. The providers’ likeliness to prescribe in the next six
months were measured by one question on a 4-point Likert scale. Hence, this question revealed
whether the intervention did pose an impact on the providers’ likeliness to prescribe. The
participant responses were analyzed to determine the participants’ likeliness to prescribe PrEP
after completing the online PrEP tutorial.
Primary Data Analysis
The anticipated outcomes were evaluated by measuring the constructs of PrEP clinical
knowledge, comfort, confidence and likeliness to prescribe. The project’s variable table was
created to evaluate retail NPs’ survey scores throughout the three survey phases (see Appendix
K). A paired t-Test and repeated measures ANOVA were conducted to determine differences in
pre, post, and 30-day post PrEP tutorial intervention. Thus, the outcomes being measured were
the composite scores for pre- to post-surveys and for pre, post and retention surveys. Also, the
final knowledge score was examined to assess the level of retention loss following 30 days after
the post-survey period. The outcomes measured for this aim, as the essence of this project, were
to compare the constructs’ composite scores to highlight if changes had occurred after delivery
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of the education intervention. Furthermore, the retention survey was an evaluation of NPs’
likelihood of retaining the benefit of the education intervention already received more than 30
days ago.
Description of the Software
All the surveys and the education tutorial were accessed through Survey Monkey links
that were delivered through the organization’s emails. Survey data were collected using the
Survey Monkey platform. A data dictionary was created to organize the collection of the survey
data (Appendix L). After the survey collection period, data was downloaded and stored in Excel
spreadsheets. By using the Excel spreadsheet, data were “cleaned” to remove all incomplete
surveys and organized according to the data dictionary. Data were organized with appropriate
data codes, and each constructs’ total scores were obtained using Excel’s mathematical formulas.
After organizing all valid data, the Excel spreadsheet’s working datasheet was exported to
Statistical Package for the Social Sciences (SPSS). The SPSS version used for data analysis was
SPSS version 27. SPSS was used to analyze the data to generate descriptive statistics for the
analysis of means, percentages and standard deviations. The statistical tests chosen for this
project were the paired t-Test, one-way repeated measure ANOVA, and Friedman’s Rank
ANOVA.
Needed Resources
Resources required for the PrEP Education Intervention included time, dedication, and
effort into developing the intervention and the overall project for the student investigator. The
budget for implementing this project was minimal. As shown in the project’s budget table, the
total monetary budget for this project was less than $1,000 (see Appendix M). Aside from the
learners’ engagement time and effort, this education intervention did not need any organizational
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resources. Despite the minimal cost spent, the potential of this project’s impact may be
monumental.
Results
Sample Characteristics
A total of 39 nurse practitioners participated in the pre- and post-surveys and completed
the online educational tutorial. Participants’ ages ranged from 28 to 56 years with a mean age of
39.0 years (SD = 8.89). On average, they had over six years of nurse practitioner experience (M
= 6.35, SD = 8.98). Thirty-eight were females and one was male. Twenty-nine percent of the
participants identified their race/ethnicity as African American or Black, 24% identified as
Asian, 3% identified as Hispanic or Latino, 37% identified as White/ Non-Hispanic, and 8%
selected “Other.” Eighty-seven percent of the participants were employed full-time, whereas 3%
were employed regular part-time, 8% were casual employees or committed part-time, and 3%
selected “Other.” For education status, 76% of nurse practitioners held an MSN or master’s
degree and 24% held a DNP/Doctorate (see Table 4).
Participants were asked about their prior experience with PrEP (see Table 5). Although
over 97% of participants had heard about PrEP, less than 50% of participants had ever initiated a
conversation about PrEP with a patient. More than 65% of participants indicated that they did
have patients ask about PrEP, but almost half of the participants had never had any experience
prescribing PrEP. Additionally, when participants were asked about their prior knowledge of the
potential side effects of PrEP’s, less than 50% rated their knowledge as “Good” or “Very Good.”
Data accuracy was achieved by rechecking survey data against an Excel spreadsheet by
two members of the project group. The refined Excel data was exported to SPSS 27 which was
used for the statistical analysis. There was one survey with a missing composite score for the

THE PREP EDUCATION INTERVENTION

35

comfort construct. This did not significantly impact the results of the analysis.
Pre- vs. Post-Survey Scores
A paired t-Test was performed to assess differences in the 39 participants’ pre and post
intervention knowledge of PrEP clinical practice, comfort screening at-risk HIV individuals, and
confidence in prescribing PrEP (see Table 6). Analyses revealed a significant difference (t (38) =
5.16, p < 0.001) between the pre-survey scores (M = 6.44, SD = 1.37) and post-survey scores (M
= 8.10, SD = 1.65) for knowledge of PrEP clinical practice. There was a significant difference in
the pre-survey scores (M = 9.97, SD = 3.41) and post-survey scores (M = 11.74, SD=3.14) for
comfort screening at-risk HIV individuals; t (37) =2.67, p <.008. Confidence in prescribing PrEP
was significantly different based on the pre-survey (M = 19.54, SD = 6.79) andpost-survey
scores (M = 24.18, SD = 5.70); t (38) = 4.29, p < .001). Overall, the online tutorial intervention
had a significant effect on all three constructs: knowledge, comfort, and confidence.
Post- and Retention Surveys
Three one-way repeated measures ANOVA within-subjects analysis was performed to
assess the effects of the PrEP education intervention on knowledge of PrEP clinical practice,
comfort screening at-risk HIV individuals, and confidence in prescribing PrEP for the 31
participants who completed the pre-, post-, and retention surveys. Figure 3 presents the mean
scores for the three survey phases in a diagram. Likewise, themean scores and descriptive data
for the repeated measures of knowledge of PrEP clinical practice are depicted in Table 7. There
was a significant main effect of the PrEP education intervention on providers’ knowledge of
PrEP clinical practice (F (2, 60) = 13.83, p < .001, η p 2 = 0.315). Post hoc tests for pairwise
comparisons using the Bonferroni correction revealed that participants’ knowledge of PrEP
clinical practice increased significantly between the pre-survey(M = 6.23; SD = 1.36) and post-
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survey (M = 8.13; SD = 1.65; p < .001). Participants’ knowledge of PrEP clinical practice also
increased significantly between the pre-survey (M = 6.23; SD = 1.36) and retention phase (M =
7.19; SD = 1.78; p = .020). Participants’ knowledge of PrEP clinical practice post-survey scores
and retention scores were not significantly different (see Table 8).
Figure 4 depicts mean scores for the comfort construct measured at 95% confidence
interval that was obtained from the three survey phases. Specifically, this construct assessed
whether the PrEP education intervention affected providers’ comfort screening “at-risk HIV”
individuals. Table 9 presents the mean scores with the standard deviation for the 30 participants.
There was a significant main effect of the PrEP education intervention on the participants’
comfort screening at-risk HIV individuals (F (2, 58) = 8.26, p = .001, ηp2 = 0.222). Post hoc tests
for the pairwise comparisons using the Bonferroni correction revealed that participants’ comfort
screening “at-risk HIV” individuals increased significantly between the pre-survey (M = 10.0;
SD = 3.57) and retention phase (M = 12.50; SD = 3.38; p = .001). Participants’ comfort
screening “at-risk HIV” individuals pre-survey scores (M = 10.0; SD = 3.57) were not
significantly different from the post-survey scores (M = 11.67; SD = 10.41; p = .08) and their
post-survey scores and retention scores were not significantly different. Table 10 presents the
comfort construct findings that were notable in the repeated measures ANOVA analysis (see
Appendix S).
Figure 5 represents mean scores for the confidence construct measured at the 95%
confidence interval that was obtained from the three survey phases. The mean and the standard
deviation for the 31 participants is shown in Table 11. As notable in Table 12, there was a
significant main effect of the PrEP education intervention on confidence in prescribing PrEP
(F (2, 60) = 21.50, p < .001, ηp2 = 0.413). Post hoc tests for the pairwise comparisons using the
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Bonferroni correction revealed that participants significantly increased their confidence in
prescribing PrEP from the pre-survey scores (M = 19.65; SD = 7.00) compared to the postsurvey scores (M = 24.90; SD = 5.47; p < .001). Participants significantly increased confidence
in prescribing PrEP from the pre-survey scores (M = 19.65; SD = 7.00) compared to the
retention surveys (M = 25.48; SD = 4.12; p < .001). Participants’ confidence in prescribing PrEP
post-survey scores and retention scores were not significantly different (p > .999). As shown in
Appendix V’s table, the improved confidence to prescribe PrEP following the intervention can
be noted through the repeated measures ANOVA analysis. Figure 6 is a bar graph which depicts
the mean scores across all phases of the survey for the knowledge, comfort and confidence
constructs. Across all constructs, retention scores differed from pre-survey scores, but did not
differ from post-survey scores.
Likeliness to Prescribe PrEP
A Friedman’s rank ANOVA test was performed on data collected from the 31
participants who completed the pre-, post-, and retention survey to assess one ordinal item
regarding likeliness to prescribe PrEP in the next six months. Figure 7 displays the mean
rankings for the pre-, post- and retention surveys. The results indicated that rankings for
likeliness to prescribe were rated significantly different in the three groups (χ2(2) = 22.45, p <
.001). The Post hoc tests for the pairwise comparisons using the Bonferroni correction revealed
that participants’ likeliness to prescribe PrEP increased significantly from the pre-survey’s mean
ranking of 1.52 compared to the post-survey’s mean ranking of 2.17 with p = .04. Participants’
ratings of likeliness to prescribe PrEP significantly increased from the pre-survey’s mean ranking
of 1.52 compared to the retention survey’s mean ranking of 2.32 with p =.01. Participant’s
likeliness to prescribe PrEP for the post-survey and retention survey were not significantly
different (see Table 13).

THE PREP EDUCATION INTERVENTION

38

Discussion
Many researchers have studied various forms of education and training to promote PrEP
as an HIV prevention strategy. Specifically, there were many studies focused on targeted
education for the frontline primary care providers. The current QI project was aimed at
enhancing retail NPs' ability to perform PrEP related encounters, especially with the “at-risk
HIV” patients. Indeed, the project’s online PrEP tutorial was effective in improving knowledge
of PrEP clinical practice, comfort screening “at-risk HIV” patients, confidence in prescribing
PrEP, and the likeliness to prescribe PrEP in the next six months for retail health clinic providers.
Pre-survey revealed demographic characteristics as well as valuable baseline scores. The
diverse group of NPs was mostly females with over six years of advanced nursing practice
experience. The average age of participants was 39 years. This “mature” age suggests that the
practitioners had additional various clinical nursing experiences. While almost everyone had
heard about PrEP, more than half of the NPs had ever initiated a conversation about PrEP with a
patient. Survey results suggested that only about half of the participants had ever prescribed
PrEP before. Less than 10% had “excellent” or “very good” knowledge about PrEP’s potential
side effects. Despite the NPs’ veteran status, the participants lacked knowledge about PrEP’s
prescribing practices. In addition to the participant characteristics, baseline scores for all
constructs were obtained through the pre-survey.
Post-survey scores were evaluated against baseline scores to note the effects of the
education intervention. Participants demonstrated improved scores for all constructs in the postsurvey that immediately followed the education tutorial. Despite the online PrEP tutorial taking
only 30-40 minutes to complete, the NPs’ increased knowledge score was most impressive. The
presentation’s evidence-based content in an easy to access, engaging format with practice
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scenarios may have been an important factor in achieving positive knowledge gain results. This
finding is in line with many studies that used longer PrEP training sessions (Irungu et al., 2019;
Sales et al., 2019; Newman et al., 2019). Another recent study by Phillips et al. (2020) also found
effectiveness of an education intervention administered in California’s federally qualified health
centers. An impressive knowledge gain for all twelve providers with post-test scores of 90% or
greater was noted after a weeklong comprehensive evidence-based PrEP training. More
importantly, Phillips et al. (2020) found a significant increase of 67% in writing PrEP
prescriptions. The study’s positive outcome reinforces the need for PrEP education and training
aimed at frontline providers in primary care settings (Phillips et. al., 2020). Hence, the postsurvey results echo the positive results that were found in previous studies and reinforces the
need to provide education and training to NP providers.
The third phase of the survey was unique to this PrEP Education project. Participants
completed the retention survey anywhere from four to ten weeks after viewing the online PrEP
tutorial. With only 31 subjects that participated in the 30-day retention survey, the mean
knowledge score marginally declined (about 8%) between the post- and retention surveys. Since
it is impossible to not forget newly acquired information, some loss of knowledge was to be
expected. The infamous phenomenon discovered in the 1880s, the “Forgetting Curve” suggested
that trainees forgot about 50% of the learned material in the first hour and about 70% within the
first 2-hour period (Davidson, 2016). Hence, ongoing updates and educational refresher courses
will be beneficial to retain and reinforce important clinical knowledge. Moreover, with a larger
number of participants completing the retention survey, this study could have found the
knowledge score loss not to exceed the 5%. The unexpected knowledge loss could also be related
to the current pandemic that had affected the daily workflow. All clinics confronted revenue loss
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with a very low number of daily patient visits as well as fewer patients seeking STI screening
needs. At the same time, the organization focused on redirecting the clinic workflow to adopt
new coronavirus-related services. All providers were inundated with new training material as
well as adapting to the pandemic’s unprecedented workflow.
Overall, participants demonstrated improved comfort screening “at-risk HIV” patients
after viewing the PrEP education tutorial. However, there were no significant differences in
providers’ pre-and post-survey ratings regarding their comfort in screening “at-risk HIV”
patients. Likewise, Newman et al. (2019) found the medical residents’ comfort assessing PrEP’s
clinical eligibility did not achieve a statistical significance despite their improved comfort
prescribing PrEP after the 1-hour education session. The four-item section presented sensitive
case scenarios of screening patients based on his/her gender and sexual preferences. By the third
phase of the survey, NPs did increase their comfort level in asking the PrEP screening questions
that explored patients’ sexual practices. Interestingly, the organization launched its updated HIV
prophylaxis guideline in late September 2020. More emails and reminders about the updated
clinical guideline were being announced just before the retention survey was sent out. This
could have encouraged providers to revisit their comfort level about the topic of PrEP and STI
screenings. By the third phase of the survey, the participants increased their ratings for their
comfort level to identify the “at-risk” HIV patients. Hence, this finding may be related to
providers who had some time with repeated exposure to the PrEP topic that encouraged more
consideration to become “comfortable” with this sensitive subject.
Participants’ confidence with PrEP prescribing practices showed improved scores
throughout the survey phases. Indeed, the PrEP tutorial promoted knowledge about potential side
effects and required laboratory data for ongoing PrEP follow-up visits. NPs' improved
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confidence with PrEP prescribing practice suggested the knowledge gained about the national
PrEP clinical guidelines.
Participant responses to the likeliness to prescribe in the next six months showed
favorable results. There was a steady increase for all phases of the survey. Compared to the
baseline, participants were more likely to prescribe PrEP immediately following the intervention
and 30 days following the intervention. Phillips et al. (2020) demonstrated a 67% increase in
PrEP prescriptions following a week-long educational intervention based on the national PrEP
clinical guideline. Although this QI project did not conduct a retrospective review of the
organization’s electronic medical record, the study’s data signaled a promising perspective. This
relevant finding suggested that participants did gain knowledge, comfort, and confidence related
to PrEP practices after participating in the PrEP tutorial intervention. Their intent to confidently
prescribe PrEP was recognized to symbolize improved care for the “at-risk HIV” patients.
Educational Implications
Nurse practitioners are lifelong learners that will seek ongoing education and training
throughout their careers. Online education in various shapes and forms have become widely
available and acceptable to meet the nursing professional needs and development. Quality online
educational design that is engaging and interactive will be more suitable in engaging learners that
promote a positive learning experience. Rouleau et al. (2019) conducted a systematic review on
effects of e-learning on nursing care activities. Using the Kirkpatrick model’s levels of
evaluation, Rouleau et al. (2019) found 59% of reviewed studies had positive outcomes related to
e-learning. Specifically, e-learning interventions improved nurses’ knowledge in many subjects
such as medication administration and calculation (Rouleau et al., 2019). Likewise, the PrEP
tutorial’s interactive design with clinical case scenarios had a positive impact on NPs. When
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compared to the pre-intervention baseline, NPs had learned many aspects about PrEP clinical
practice that instilled their confidence and likeliness to prescribe PrEP in the near future. Overall,
the online PrEP tutorial provided a low cost, yet robust way to educate NP providers about PrEP.
Implications for Practice
The PrEP education project’s findings supported the value of increasing providers’
knowledge through participation in an online training tutorial. Based on the CDC’s PrEP clinical
guideline (CPG; CDC: U.S. Public Health Service, 2018), the self-paced online training had a
significant impact on the organization and the community. Study results suggested that the Retail
Clinic’s NPs were better equipped to engage in PrEP discussions with more patients with an
improved ability to initiate PrEP. Their improved ability to screen for PrEP candidacy also
implied their confidence with PrEP’s national CPG (CDC: U.S. Public Health Service, 2018).
NPs’ increased understanding of PrEP is critical to delivering enhanced quality care
for patients that may be “at-risk” for HIV. Retail clinic NPs’ improved ability to offer safe
PrEP related patient encounters ultimately benefits the communities and the nation.
Instilling NPs with the knowledge to fuel comfort about screening candidacy and
confidence about prescribing PrEP should reveal improved patient outcomes that predict
lower HIV infection rates.
Implications for Healthcare Policy
The national initiative to dramatically lower HIV infections had spiraled the urgency for
broader PrEP uptake. The “A Plan for America” involved prevention as one of its four key
strategies along with “diagnosis,” “treatment” and “respond” themes. Under the prevention topic,
PrEP was highlighted with an emphasis on the national clinical PrEP guideline, educational
campaigns, and the PrEP Locator program (CDC, 2020c). Interestingly, the Kaiser Family
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Foundation’s report revealed that 34.8 billion was spent on HIV-related efforts in 2019 with only
3% of the total federal budget towards domestic HIV prevention efforts (Kaiser Family
Foundation, 2019). Since the national plan parallels the current HIV epidemic, more funding
should be allocated towards education aimed at improving provider knowledge about PrEP and
the CDC’s national clinical guideline. All primary care practices should encourage their frontline
providers to engage in an online self-paced training opportunity that may enhance their current
knowledge on PrEP clinical guidelines. Also, national credentialing organizations for nursing
education may influence advanced practice nursing programs to make curriculum enhancements
that mirror the current public health efforts. Nurse practitioner programs could easily incorporate
a brief online PrEP module to improve NP students’ knowledge about PrEP clinical guidelines
and their role in ending the HIV epidemic for the nation.
Implications for Executive Leadership
Clinical leaders must continuously evaluate evidence-based practice and disseminate
research findings that reinforce new practice protocols. With any newer guideline updates, the
education team should offer training sessions. Organizational leadership should provide the
needed resources that are required to develop engaging education tutorials. Since certain
sensitive health topics will require various forms of training, the executive leadership should
make a PrEP tutorial available on its intranet for the newer providers.
Implications for Quality/Safety
Recent trends in healthcare highlight the urgency to provide safe patient care that can
deliver measurably improved outcomes. Education tutorials that can enhance providers’ ability to
convey better patient care should be recognized. The improved composite scores for knowledge,
comfort, and confidence constructs suggest that NPs could influence better outcomes for patients
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“at-risk” for HIV. With improved ability to screen for candidacy, NPs will be knowledgeable
about how to safely treat these patients prophylactically to prevent HIV infections. The “at-risk
HIV” patients who meet the criteria for PrEP will receive safe quality-driven care. Measurable
outcomes for communities will support the national goal to lower 75% of HIV infections by the
year 2025 (HIV.gov, 2019).
Limitations
This quality improvement project delivered for two regions in the mid-Atlantic area of
the country lacks the ability to generalize for the entire nation. The study’s findings pertained to
one retail clinic organization’s small group of NPs that were not recruited through a random
sampling method. Also, the current analysis cannot conclude which construct variable best
predicts NPs’ likeliness to prescribe in the next six months.
Plans for Sustainability
This QI project’s tutorial should be available on the organization’s intranet site. Other NP
staff pursuing DNP degrees will have the opportunity to learn about the details of the study. The
tutorial link can be available to offer to new onboarding staff who are new to retail clinic or
newly graduated from NP programs. Other possible ideas for further dissemination of the PrEP
tutorial are to current family practice nurse practitioner students who are in their final semester
ready to graduate from their programs and dissemination to local nurse practitioner organization
chapters.
Future Direction
A larger random sample size from various regions of the country may provide better
insight into the value of delivering an online PrEP tutorial for retail clinic nurse practitioners.
Advanced statistical regression analysis could predict whether the knowledge, comfort, or
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confidence construct might best influence NPs’ likeliness to prescribe PrEP. Additionally,
retrospective analysis of aggregate patient data to evaluate the number of actual PrEP
prescriptions would highlight further insight into the intervention’s impact on improving PrEP
uptake.
Conclusion
Despite the proven efficacy of PrEP, the uptake has been less than desirable in
confronting the HIV epidemic. The organization’s retail health clinics located throughout the
communities are the “PrEP Providers” answering the nation’s call to reduce the HIV infections
that disproportionately affect the southern part of the country, including the capital, Washington
DC. The evidence-based PrEP Education Intervention online tutorial was designed to instill
knowledge, comfort and confidence for busy frontline nurse practitioners. This quality
improvement project successfully demonstrated improved post-intervention survey scores to
reflect enhanced PrEP knowledge, comfort identifying at-risk HIV candidates, and confidence
with PrEP prescribing practices. Moreover, an improved score for NPs’ likeliness to prescribe
PrEP in the next six months signified increased opportunities to prescribe PrEP to the “at-risk
HIV” patients. Hence, this intervention contributed to building a team of NP champions ready to
conduct quality-driven PrEP encounters and prescribe PrEP for those meeting the criteria.
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Appendix A

SWOT Analysis

•

Internal Origin

•

•

•

•

External Origin

•
•
•
•
•
•

Strengths
(To achieving the
objectives)
Strong branding; Retail
clinicsnationwide
Well-known for convenience
and quality; high patient
satisfaction rate
Innovative retail health concept
usingEBP clinical guidelines;
experienced and engaged
leadership
Dedicated clinicians;
educational &professional
advancement opportunities
Magnet status and encourages
"newknowledge, innovation
and improvements"
DC with high HIV incidence rate
Increased public awareness
about PrEP with the national
HIV preventioneffort
Projected population growth
for DCmetro region
Public familiarity with retail
healthclinics
Generic version of Truvada
available
USPTF’s PrEP
recommendationupdated
to an “A” rating

•
•
•
•

•

•
•

•

Weaknesses
(To achieving the
objectives)
Inexperienced providers
withknowledge and skill
deficit
Busy clinic setting and little
timeto engage in new learning
activities
Lack of NP interest with
PrEPtopic
Organization does not permit use
of any deidentified patient data
orrevealing company name for
DNPprojects
No network of infectious
diseasespecialists for potential
referrals
Uninsured patients unable
toafford cost of clinic visits
Failure of Health Hub initiative
toincrease “young adult” health
services
Decreased overall patient volume

THE PREP EDUCATION INTERVENTION

55
Appendix B
Evidence Table

Article #

1

Author &
Date

Centers for
Disease
(nonresearch) Control and
Prevention
(CDC)
(2018)

Evidence
Type
Clinical
Practice
Guideline
(update from
2014)
RCT’s and
pilot studies

Sample,
Sample Size,
Setting
Multiple
settings and
sample sizes,
including
international
studies
Males,
females &
transgender
(n=20 to
>1250)

2

Clement,
Quasi
M.E.,
experimental
Seidelman,
J., Wu, J.,
Alexis, K.,
McGee, K.,
Okeke, N.L.,
Samsa, G., &
McKellar,
M. (2018)

Primary care
providers
(PCP) of the
Duke
University
Health
System in
Durham, NC
for pre & post

Findings that help
answer the EBP
Question

Observable
Measures

Limitations

Evidence
Level

Evidence of need
for additional HIV
prevention;
Evidence of safety
and efficacy of
antiretroviral
(ARV)
prophylaxis;
Identification for
PrEP indications;
PrEP practice
(goals of therapy
and monitoring
needs)

Safety and
efficacy of ARV
use in clinical
trials

No validated tool
for risk
assessment; Lack
of PrEP
eligibility
algorithm in a
visual format

An educational
initiative
improved PrEP
knowledge and
prescribing
practices for PCPs

Pre and post
education
intervention
survey results
(PrEP practice
patterns:
Likeliness to
prescribe PrEP,
knowledge &

Selection &
Level II &
response bias:
B quality
Lack of
generalizability
due to
respondents at
universityaffiliated
institution in
South; pre & post

& Quality
Level I &
A Quality
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Evidence
Type

Sample,
Sample Size,
Setting
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Findings that help
answer the EBP
Question

Observable
Measures

Limitations

Evidence
Level
& Quality

intervention
survey;

comfort with
PrEP practice)

pretest n=33;
intervention
n=30 & n=79
for post
intervention
survey only

60% cited lack of
knowledge as
reason
Reported
prescribing;
42% lack of
comfort as
reason for not
prescribing;
PrEP prescribing
pre intervention
was 17% vs 35%
post education
intervention

surveys were not
linked
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Article #

3

Author &
Date
Edelman,
E.J., Moore,
B.A.,
Calabrese,
S.K.,
Berkenblit,
G.,
Cunningham,
C.O.,
Ogbuagu, O.,
Patel, V.V.,
Phillips,
K.A.,
Tetrault,
J.M., Shah,
M. &
Blackstock,
O. (2019)

Evidence
Type
Cross
Sectional
online
survey
(Descriptive
Study)
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Sample,
Sample Size,
Setting

Findings that help
answer the EBP
Question

Observable
Measures

240 urban
primary care
physicians
affiliated with
academic
institutions
Members of
Society of
General
Internal
Medicine
(SGIM)

Provider training
and clinic-specific
PrEP protocols
may promote
PrEP implementation towards
improving wider
PrEP uptake

Practice
characteristics:
Provider
preferred PrEP
implementation
model (All
provider training
vs inhouse PrEP
specialist vs refer
out)

Limitations

Evidence
Level
& Quality

85% of
physicians
favored PrEP
integration
through:
Training (42%)
Onsite specialist
(43%)
Refer out (15%)

Original survey
was from 2015
using a
convenience
sample; all
respondents were
associated with
academic
institutions; lack
of
generalizability
to non-academic
and communitybased providers
and non-urban
settings; did not
include other
providers such as
NPs, family
physicians; lack
of descriptions
for response
values for the
Likert scales
(i.e., “2” & “3”
explanation)

Level III &
B Quality
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Author &
Date
Henny, K.
D., Duke,
C.C.,
Buchacz, K.,
Brooks, J. T.,
Samandari,
T., Sutton,
M. Y.
(2019)

Evidence
Type
Cross
Sectional
online
survey
(Descriptive
Study)
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Sample,
Sample Size,
Setting

Findings that help
answer the EBP
Question

Observable
Measures

820 PCPs
practicing in
South Eastern
high HIV
burden areas
(Atlanta, GA,
Baltimore,
MD, Baton
Rouge, LA,
Miami, Fl,
New Orleans,
LA,
Washington,
DC)

PCPs who
prescribed PrEP
had self-reported
good
understanding of
PrEP and more
likely to prescribe
provide primary
care for persons
with HIV

PCP’s practice of
prescribing
nPEP; PrEP &
ART

Use of
antiretroviral
therapy (ART)
may be increased
with provider
comfort and
familiarity

Limitations

Evidence
Level
& Quality

PCP
demographics;
prior HIV
training;
knowledge,
behaviors,
attitudes and
practices of HIV
related care
More than 52%
providers lacked
knowledge
Adjusted
prevalence rate
for PrEP’s
familiarity was
(aPR=4.35, 95%
CI 2.63, 7.14)

Possible
measurement
error since
survey response
choices were all
dichotomous
categories (i.e.
yes/no)

Level III &
B Quality
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Article #

5

Author &
Date
Henny, K.
D., Duke,
C.C.,
Buchacz, K.,
Brooks, J. T.,
Samandari,
T., Sutton,
M. Y.
(2019)

Evidence
Type
Cross
Sectional
online
survey
(Descriptive
Study)

Sample,
Sample Size,
Setting
820 PCPs
practicing in
South Eastern
high HIV
burden areas
(Atlanta, GA,
Baltimore,
MD, Baton
Rouge, LA,
Miami, Fl,
New Orleans,
LA,
Washington,
DC)

59
Findings that help
answer the EBP
Question
Positive
correlation exists
between provider
training and
delivery of PrEP
services
Educational
intervention is
needed in the
South to
strengthen PrEP
familiarity for
PCPs

Observable
Measures

Limitations

Evidence
Level
& Quality

Only 1/3 of PCPs
reported any HIV
related training
in the last 24
months; PCPs
with HIV-related
training were
likely to provide
PrEPè
PCPs with HIV
related training
compared to no
training were
more familiar
with PrEP (aPR1.67, 95% CI
1.19, 2.38) and
to ever have
prescribed PrEP
to patients)
aPR=1.75, 95%
CI 1.1., 2.78)

Possible
measurement
error since
survey response
choices were
dichotomous
categories (i.e.
yes/no)

Level III &
B Quality
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Article #

6

Author &
Date

Evidence
Type

Irungu, E.M., Quasi
Ngure, K.,
experimental
Mugwanya,
K., Mugo,
N., Bukusi,
E., Wamoni,
E., Odoya, J.,
Morton, J.F.,
Bernabee,
G., Mambo,
B. Masyuko,
S., Mukui, I.,
O’Malley, G.
& Baeten,
J.M. (2019)
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Sample,
Sample Size,
Setting

Findings that help
answer the EBP
Question

Observable
Measures

541 health
workers (HW)
of Kenya’s
public health
facilities
participated in
a 2-day PrEP
for HIV
serodiscordant
couples;
Pre-test and
post-test study
design called,
“Partners
Scale-UP
Project”

Standardized
training improved
PrEP knowledge
and confidence of
HW to provide
PrEP to HIV
serodiscordant
couples

Among all HW
that completed
both pre & posttests, Pretraining
mean of 61.7%
increased to post
training of 86.4%
(SD 12.7);
increase of
24.7% (95% CI
23.3-26.1,
p<0.001) in
mean scores

Limitations

Evidence
Level
& Quality

30% HW felt
very
uncomfortable
prior to training
and post training,
number was
reduced to 11.7%
Providers gain in
comfort post
intervention
(from 22.8 % to
67.3%, p<.001)

Study did not
Level II &
assess the
B quality
retention of
knowledge and
skills after the
training; also, did
not measure the
effect of training
on quality of
PrEP service
delivered to the
community
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Article #

7

Author &
Date
Newman, R.,
Katchi, T.,
Karass, M.,
Gennarelli,
M., Goutis,
J., Kifayat,
A., Solanki,
S.,
Yandrapalli,
S., Forman,
L. & Nabors,
C. (2018)

Evidence
Type
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Sample,
Sample Size,
Setting

Findings that help
answer the EBP
Question

Quasi
48 medical
experimental residents in an
academic
internal
medicine
residency
program that
participated in
the
educational
session;
45completed
pre-test and
36 completed
post-tests
following an
hour-long
intervention

Pre-test awareness
of PrEP was 22%.
78% believed
PrEP was
effective, 66%
believed PrEP was
safe 62%; had fair
or poor knowledge
of side effects
Post-test revealed
- 94% believed
PrEP was
effective, 92% for
PrEP safety;
likeliness to
prescribe PrEP
pre-test was 32%
& post-test
revealed 67% to
prescribe in the
next 6 months

Observable
Measures

Limitations

Evidence
Level
& Quality

Pre and post
education
intervention
survey results
(PrEP practice
patterns:
Likeliness to
prescribe PrEP,
knowledge &
comfort with
PrEP practice)
22% out of 45
surveyed were
not at all familiar
with PrEP prior
to education
intervention
Reported
likeliness to
prescribe PrEP pre intervention
was 35% vs 67%
post education
intervention

Selection &
response bias:
Lack of
generalizability
due to
respondents at
universityaffiliated
institution in
South (medical
students); pre &
post surveys
were not linked

Level II &
B quality
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Article #

8

Author &
Date
Sales, J.M.,
Cwiak, C.,
Haddad,
L.B.,
Phillips, A.,
Powell, L.,
Tamler, I.,
and Sheth,
A.N. (2019)

Evidence
Type

Sample,
Sample Size,
Setting

Quasi
28
experimental providers/staff
members
working in
safety net
family
planning (FP)
clinics in
Atlanta, GA
Staff included
physicians,
NPs, health
educator,
clinic
manager for
the region’s
four clinics

62
Findings that help
answer the EBP
Question
Providers’
knowledge and
confidence for
PrEP improved
after a 1.5-hour
education session

Observable
Measures

Limitations

Evidence
Level
& Quality

PrEP knowledge
before training
was M=3.26 vs
post M=5.13 (SD
= 1.1.8)
Provider
confidence in
identifying
patients at HIV
risk was preM=8.11 vs post
M=9.11, p =.007
Only 19% of
staff members
had previously
heard of PrEP
and only 7%
were aware of
USPHS
guidelines prior
to education
intervention

A convenience
sample of family
planning clinic
staff that
included nonproviders; did
not train every
staff member for
each clinic

Level II &
B Quality
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Article #

9

Author &
Date

United States
Preventive
(nonresearch) Task Force
(USPTF)
(2019)

Evidence
Type
Scientific
reviews of
various
evidencebased highquality
research that
had been
conducted
Consensus;
Position
Statement of
national
expert
committee
appointed by
AHRQ –
based on
high quality
evidence

Sample,
Sample Size,
Setting
N/A

63
Findings that help
answer the EBP
Question

Observable
Measures

“A” grade for the
position that
clinicians should
offer PrEP to
persons at risk of
HIV transmission

Effectiveness of
risk assessment;
PrEP efficacy;
Potential risk
assessment;
Estimate
magnitude of net
benefit

Limitations

Evidence
Level
& Quality

Did not address
regional
differences in
PrEP uptake;
Does not discuss
the providers’
roles in
addressing PrEP
practice; does not
discuss lack of
provider
knowledge

Level I &
A Quality

THE PREP EDUCATION INTERVENTION
Article #

10

Author &
Date
Wilson, K.,
Beckett,
C.G.,
Blaylock,
J.M.,
Okulicz, J.F.,
Scott, P. T.,
Hakres, S.
(2020)

Evidence
Type
Cross
Sectional
online
survey
(Descriptive
Study)

Sample,
Sample Size,
Setting
432
Active U.S.
Navy
providers in
various
specialties
(family
medicine,
infectious
disease,
internal
medicine,
occupational
health,
pediatrics)

64
Findings that help
answer the EBP
Question

Observable
Measures

PrEP Knowledge
gap exists
amongst Navy
Providers despite
military’s
provision of PrEP;
Training to
improve
prescribing
practice
knowledge and
sexual history
taking may be
useful

Number of
patients seen
monthly; comfort
discussing sexual
risk behaviors;
frequency of
querying patients
about sexual
activities;
frequency of
prescribing
PrEP;
Knowledge of
CDC guideline
on PrEP

Limitations

Evidence
Level
& Quality

Poor knowledge
(17.1%); Ever
prescribed PrEP
(19%)
Provider
knowledge about
PrEP directly
correlated with
their likeliness to
prescribe PrEP
(29% vs 6%)

Participation bias Level III &
– respondents
B Quality
more interested
in HIV
prevention;
survey limited to
military
providers and not
generalizable for
non-military
providers; 22item lengthy
survey leading to
survey-fatigue
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Article #

11

Author &
Date
Wood, B.R.,
Mann, M.S.,
MartinezPaz, N.,
Unruh, K.T.,
Annese, M.,
Spach, D.H.,
Scott, J.D. &
Stekler, J.D.
(2018)

Evidence
Type

Sample,
Sample Size,
Setting

Quasi
Medical
experimental providers on
the HIV
(Pilot teleECHO email
mentoring
list (Extension
program)
for
Community
Healthcare
Outcomes);
Program was
out of Seattle,
WA and
supported
HIV
practitioners
in NW region
of country
n=24 pre-test
n=45 post-test

65
Findings that help
answer the EBP
Question

Observable
Measures

Continuous
education and
support improved
providers ability
to stay current on
PrEP guidelines
and improved
prescribing
confidence

Adding PrEP
distance
curriculum into
existing Project
ECHO improved
medical provider
knowledge and
comfort with
PrEP

Limitations

Evidence
Level
& Quality

Pre and post
Level II &
intervention
C Quality
surveys were not
matched;
insufficient
sample size; no
measure of
statistical
significance; low
overall response
64% responded
rate; qualified for
“extremely” and post survey
12 %
criteria was
“moderately” that based on at least
PrEP Echo
one session;
increased their
possible
likelihood to
responder bias;
prescribe PrEP
study was limited
to one region of
the country
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Article #

12

Author &
Date
Zhang, C.,
McMahon,
J., Fiscella,
K., Przbyla,
S.,
Braksmajer,
A., LeBlanc,
N. & Liu, Yu
(2019)

Evidence
Type
Systematic
review

66

Sample,
Sample Size,
Setting

Findings that help
answer the EBP
Question

18,265 health
care
professionals
(HCP) in
various
settings from
36 studies
were assessed

Discrepancy exist
between HCPs
awareness/
willingness to
prescribe PrEP vs
low prevalence of
PrEP consultations
and actual
prescribing
frequencies;
PrEP provision
lowest among
HCP’s of South;
Barriers and
and facilitators for
PrEP implementation exist

Observable
Measures

Limitations

Evidence
Level
& Quality

Pooled
prevalence of
PrEP awareness
among HCP
(68%; 95% CI
55-80%);
willingness to
prescribe (66%;
95% CI 5477%); PrEP
consultation
(37%l 95% CI
25-52%); PrEP
prescription
(24%; 95% CI
17-32%)

Publication
biases – type 1
errors; high
heterogeneity of
studies due to
diverse design,
populations and
settings; scarce
data of PrEP
implementation
in certain
specialists;
compromised
precision and
validity of
estimates due to
arbitrarily
categorizing
participants (i.e.
NPs & PAs into
one grp)

Level II &
A quality
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Appendix C
Iowa Model Revised
Figure 1. Iowa Model Revised: Evidence-Based Practice to Promote Excellence in Health Care

(Iowa Model Collaborative, 2017)
Used/reprinted with permission from the University of Iowa Hospitals and Clinics, copyright 2015.
For permission to use or reproduce, please contact the University of Iowa Hospitals and Clinics
at 319-384-9098
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Appendix D
Project Team Members
Table 1. PrEP Education Intervention Team Members
Dr. Karen Whitt
Dr. Laura Posey

Primary Advisor
Principal Investigator
Secondary Advisor

Kristina Jung, MSN

Student Principal Investigator

Linda Duquette-Petersen, MSN

Regional Quality Lead – Region 23

Carol Gibson, MSN

Region 23 Fellow, Preceptor

Hilary Summers-Royce, DNP

Regional Quality Lead – Region 22
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GWU IRB Determination
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Appendix F
Intervention Syllabus
Dear colleagues,
As frontline providers to the communities we serve, we nurse practitioners (NP) must confront
the current HIV epidemic. The national initiative endorsed by the Centers for Disease Control
and Prevention (2019), “Ending the HIV Epidemic: A Plan for America,” aims to reduce 75% of
HIV infections in the next five years and 90% by the year 2030. Importantly, Washington DC
had the highest incidence rate in the nation with 34.6% in 2018 (CDC, 2019)!
According to the Centers for Disease Control and Prevention’s site, all MinuteClinic is identified
under “PrEP Locator” listings. This means that our clinics should offer this service confidently
as well as being confident to screen for those at-high HIV risk individuals. Although this
education session is optional, I hope you can take the time to review the PrEP education session.
I hope it may enhance your knowledge and confidence in providing PrEP encounters.
Length of Education Session
Delivered online
Online Presurvey
Online Postsurvey
30-day Post intervention
Retention Survey

25-30 minutes

Purpose of Learning Session

To gain knowledge, comfort, and confidence
with PrEP clinical practice that includes
screening candidacy and prescribing PrEP

Learning Objectives

5-10 minutes
5-10 minutes
5-10 minutes

1. Learn what PrEP is
2. Learn about the potential adverse effects
of PrEP
3. Learn to assess patient’s risk of
contracting HIV to determine PrEP
candidacy
4. Learn to evaluate patients’ clinical
eligibility for PrEP
5. Learn to prepare PrEP prescriptions with
appropriate patient education and
necessary follow-ups

Centers for Disease Control and Prevention. (2019). HIV surveillance report (Volume 30)
[Report]. cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2018vol-30.pdf
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Appendix G
Intervention Methodology Map
Figure 2. PrEP Education Intervention’s Methodology Map
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Appendix H
Intervention Timeline
Table 2. PrEP Education Intervention Timeline
Completion Date

Planning

5/08/2020

Finalize DNP
Project
Proposal
Begin
developing PP
PrEP session
Obtain approval
from XYZ
Clinic’s DNP
Project
Committee

5/25/2020
7/03/2020

7/15/2020
7/20/2020
7/27/2020
Week 1
8/03/2020
Week 2
8/10/2020

PreImplementation

Implementation Evaluation

GWU IRB
submission and
approval
Complete PP
PrEP teaching
material
Reconnect with
SPMs to remind
them about
launching date

Launch the “PreIntervention
Emails
Email #1
Launch the
Pre-survey
Invitational
Emails- Presurvey
Email #2
Pre-survey
Pre-survey
Email # 2

Week 3
8/17/2020
Week 4

Launch the
Education
intervention
Emails – PrEP

Pre-survey
&
Post-survey
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8/24/2020
Week 5
8/31/2020
Week 6
9/14/2020
Week 8

9/21/2020

Week 9
10/26/2020
Week 14
11/02/2020

73
Education w/
Post-survey
Email #3
(embedded with
pre-survey)
PrEP Education
w/ Post-survey
Email # 3
(embedded with
pre-survey)

Pre-survey
&
Post-survey

PrEP Education
w/ Post-survey
Email #3
(embedded with
pre-survey)

Pre-survey
&
Post-survey

Re-launch the
PrEP Education
w/ Post-survey
(embedded with
pre-survey)

Pre-survey
&
Post-survey

Invitational
Emails – PrEP
Education w/
Post-survey
(embedded with
pre-survey)
Launch the
Retention
Survey
Invitation
Email #4
Retention
Survey

Pre-survey
&
Post-survey

Retention
Survey

Retention
Survey

Week 15
11/23/2020
Week 16

Announce Raffle Send
winners
Thank
You
emails to
everyone
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Appendix I
Informed Consent
Title of Study: The PrEP Education Intervention
IRB #:
Principal Investigator Name: Dr. Karen Whitt DNP Student Investigator: Kristina Jung
Version Date: 1/4/2019
You are invited to participate in a quality improvement project under the direction of Dr.
Karen Whitt of the Department of Nursing, George Washington University (GWU).
Taking part in this research is entirely voluntary. Further information regarding this study
may be obtained by contacting Kristina Jung (DNP Student Investigator) at
(703) 615-4300.
The purpose of this project is to evaluate clinic nurse practitioners in assessing and
prescribing PrEP. Participants will receive an educational intervention aimed at
increasing provider knowledge of PrEP to help improve screening and prophylaxis
preexposure HIV in at-risk individuals.
What are the reasons you might choose to volunteer for this project? The PrEP education
session will be provided online, at your convenience and will refresh your knowledge
about PrEP practice that includes identifying those at-HIV risk and safe prescribing.
Your participation also supports the national movement “Ending the HIV Epidemic: A
Plan for America,” which aims to reduce 75% of HIV infections in the next five years
and 90% by the year 2030.
What are the reasons you might not choose to volunteer for this project?
It does require some attention and time commitment to attend the education session
and complete the surveys.
If you choose to take part in this project, you will answer the presurvey, view the
PowerPoint learning module and answer the postsurvey. One month later, you will be
asked to answer the post survey again to test for knowledge retention. The total
amount of time you will spend in connection with this project is 20-30 minutes. The second
postsurvey will take additional 10-15 minutes. You may refuse to answer any of the
questions, and you may stop your participation in this project at any time.
Possible risks or discomforts you could experience during this project include: The risks for
participating in this project are minimal and no more than encountered in daily life.
The main risk would be confidentiality of your answers on the surveys. All survey
answers will only be accessible to the investigator, Kristina Jung, and
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individual names and answers will not be kept confidential. Results from the survey
will only be reported in aggregated, anonymous form.
You will not benefit directly from your participation in the project. The benefits to science
and humankind that might result from this study are: It may further support the need for
PrEP education for American frontline providers. PrEP education may improve
knowledge, comfort and confidence for PrEP related practice, as well as, increasing
the willingness to prescribe to those at-risk HIV patients. Frontline providers,
equipped with improved knowledge and confidence, may improve the care delivered
to the at-risk HIV patient population.
Every effort will be made to keep your information confidential, however, this cannot be
guaranteed. You will be asked to include your name on the survey, but only the
investigator, Kristina Jung, will have access to this information. After initial data is
collected your name will be replaced with an anonymous number. If results of this
research study are reported in journals or at scientific meetings, the people who participated
in this project will not be named or identified.
The Office of Human Research of George Washington University, at telephone number
(202) 994-2715, can provide further information about your rights as a research participant.
To ensure anonymity your signature is not required. Your willingness to participate in
this project is implied if you proceed with completing the surveys.
*Please keep a copy of this document in case you want to read it again.
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Appendix J
PrEP Education Survey

Token ID:
Demographics
Age in years
How many years of experience do you have as a Nurse Practitioner?
What is your Race/ Ethnicity?
1 = White/ Non-Hispanic
2 = African American
3 = Asian
4 = Other
What is your highest degree of education?
1 = MSN or master’s degree
2 = DNP/ Doctorate
What is your gender?
1 = Female
2 = Male
“Prior PrEP Experience”
1) Before today, had you heard of
PrEP?1=Yes
2=No
2) Have you ever been asked about PrEP by a
patient?1=Yes
2=No
3) Have you ever initiated a conversation about PrEP with a
patient?1=Yes
2=No
4) Have you ever prescribed PrEP to a
patient?1=Yes
2=No
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5) Before today, how would you rate your knowledge of PrEP’s potential side effects (e.g., renal
dysfunction)?
a) Excellent
b) Very good
c) Good
d) Fair
e) Poor
Provider Knowledge – 10 questions
1) Which medication has been FDA-approved for PrEP use? (FDA)
a) Maraviroc (Selzentry)
b) Tenofovir
c) Tenofovir / Emtricitabine (Truvada)*
d) Tenofovir / Emtricitabine / Efavirenz (Atripla)
e) Raltegravir + Emtracitabine (Isentress + Emtriva)
f) None has been approved
g) Not Sure
PrEP Knowledge Survey item
2) How often should patients on PrEP be followed for medication side effects and lab
toxicities after initial assessment? (PrEP Monitor)
a) Every month
b) Every 6 months
c) Every 3 months
d) Yearly
e) Not necessary to monitor after the first year
3) You are discussing PrEP with a 30-year-old male who has multiple male sexual partners.
He states he seldom wears a condom. Which clinical eligibility factors do not support the
initiation of PrEP?
a) HIV negative status, no active signs/symptoms of HIV infection, GFR > 60
b) HIV negative status, negative Anti-HBs, Negative Hep C antibody, GFR<60
c) HIV negative status, no active signs/symptoms of HIV infection, Positive HBsAg,
GFR>60
d) HIV negative status, Negative HBsAg, no fever, fatigue, pharyngitis, rash, night
sweats and adenopathy
4) Can an individual be initiated on PrEP after becoming exposed to HIV?
a) Yes. PrEP can be initiated within 72 hours of becoming exposed to HIV
b) No. PrEP must be initiated for HIV negative individuals only
c) Yes. PrEP can be taken for up to 7 days
d) Only Descovy can be started under this circumstance
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5) What are the serious side effects of PrEP?
a)
b)
c)
d)

Increased bone mineral density
Increased buildup of calcium deposits
Mild nausea and diarrhea
New or worsening renal impairment, including kidney failure

6) How effective do you think PrEP is in preventing acquisition of HIV among people who
take it every day as prescribed?
1=Not at all effective
2=Slightly Effective
3=Moderately Effective
4=Extremely Effective
7) Based on your understanding of PrEP side effects, how safe is PrEP?
1=Not at all safe
2=Slightly safe
3=Moderately safe
4=Extremely safe
8) PrEP reaches maximum protection from HIV for receptive anal sex at about how many
days of daily use?
a) 3 days of daily use
b) 4 days of daily use
c) 6 days of daily use
d) 7 days of daily use
9) For receptive vaginal sex and injection drug use, PrEP reaches maximum protection at
about how many days of daily use.
a) 7 days of daily use
b) 14 days of daily use
c) 21 days of daily use
d) 28 days of daily use
10) If a patient says he/she is using condoms consistently and correctly, how important is it to
offer PrEP in addition to condoms if you have identified the individual as possessing high
at-risk HIV?
1=Not at all important
2=Slightly important
3=Moderately important
4=Extremely important
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Provider Comfort Level - 4 questions
1) For each of the following risk behavior categories, how comfortable are you
evaluatingeligibility for PrEP?
How comfortable are you evaluating PrEP eligibility for Women who have sex with
men?
1= Not at all comfortable
2= Slightly comfortable
3= Moderately comfortable
4= Extremely comfortable
2) How comfortable are you evaluating PrEP eligibility for Men who have sex with
women?
1= Not at all comfortable
2= Slightly comfortable
3= Moderately comfortable
4= Extremely comfortable
3) How comfortable are you evaluating PrEP eligibility for Men who have sex with men?
1= Not at all comfortable
2= Slightly comfortable
3= Moderately comfortable
4= Extremely comfortable
4) How comfortable are you evaluating PrEP eligibility for People who inject drugs?
1= Not at all comfortable
2= Slightly comfortable
3= Moderately comfortable
4= Extremely comfortable
Provider Confidence - 8 questions
Each of the following risk behavior categories, how confident are you to prescribe PrEP to an
eligible individual, assuming a recent negative HIV test and equal access to medication.
1) Assuming a recent negative HIV test and equal access to medication, how confident are
you to prescribe PrEP to a female with a current male partner known to be HIVpositive?
1= Not at all confident
2= Slightly confident
3= Moderately confident
4= Extremely confident
2) Assuming a recent negative HIV test and equal access to medication, how confident are
you to prescribe PrEP to a female who has unprotected sex with male partners with
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unknown HIV status who are at high risk of HIV infection (e.g. partners(s) who has
sex with other males or uses injection drugs)?
1= Not at all confident
2= Slightly confident
3= Moderately confident
4= Extremely confident
3) Assuming a recent negative HIV test and equal access to medication, how confident are
you to prescribe PrEP to a male with a current female partner known to be HIVpositive?
1= Not at all confident
2= Slightly confident
3= Moderately confident
4= Extremely confident
4) Assuming a recent negative HIV test and equal access to medication, how confident are
you to prescribe PrEP to A male who has unprotected sex with male partners with
unknown HIV status who are at high risk of HIV infection (e.g., partner(s) who has sex
with other males or uses injection drugs)?
1= Not at all confident
2= Slightly confident
3= Moderately confident
4= Extremely confident
5) Assuming a recent negative HIV test and equal access to medication, how confident are
you to prescribe PrEP to a male with a current male partner known to be HIVpositive?
1= Not at all confident
2= Slightly confident
3= Moderately confident
4= Extremely confident
6) Assuming a recent negative HIV test and equal access to medication, how confident are
you to prescribe PrEP to a male who has sex with multiple male partners and has had
unprotected anal sex?
1= Not at all confident
2= Slightly confident
3= Moderately confident
4= Extremely confident
7) Assuming a recent negative HIV test and equal access to medication, how confident are
you to prescribe PrEP to a person who has injected drugs in the past 6 months and
shared injection equipment?
1= Not at all confident
2= Slightly confident
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3= Moderately confident
4= Extremely confident
8) Assuming a recent negative HIV test and equal access to medication, how confident are
you to prescribe PrEP to a person who has been on methadone maintenance for the
past 6 months but has continued injection drug use?
1= Not at all confident
2= Slightly confident
3= Moderately confident
4= Extremely confident
Provider likeliness to prescribe
1) How likely are you to prescribe PrEP in the next 6 months?
1= Not at all
2= Slightly
3= Moderately
4= Extremely
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Appendix K
Variable Table
VARIABLES
NP Identifier

NP Age

TYPE OF
VARIABLE
Alphanumeric,
discrete
Demographic

THEORETICAL
DEFINITION
Unique ID

OPERATIONAL
DEFINITION
System generated
unique ID

LEVEL OF
MEASUREMENT
Nominal/
Categorical

Self-reported Age
in years
Demographic Self-reported
Years of NP
experience
Demographic Self-reported
ethnic identity

Age in actual years Continuous

NP Education
level

Demographic Self-reported
highest degree of
nursing education

Nominal/
Categorical

NP Gender

Demographic Self-reported
gender

Before today,
had you heard
of PrEP?
Have been
asked about
PrEP by a
Patient?
Have you ever
initiated a
conversation
about PrEP
with Patient?
Ever
prescribed

Demographic Prior PrEP
Experience

NP years of
experience as a
provider
NP Race/
Ethnicity

Number of years
of NP experience

Continuous

Categorical:
1 = White/ NonHispanic
2 = African
American
3 = Asian
4 = Other
Categorical:
1 = MSN
2 = DNP/
Doctorate
Categorical:
1 = Female
2 = Male
3=Other
Categorical:
1=Yes
2=NO
Categorical:
1=Yes
2=NO

Categorical

Demographic Prior PrEP
Experience

Categorical:
1=Yes
2=NO

Nominal/
Categorical

Demographic Prior PrEP
Experience

Categorical:
1=Yes
2=NO

Nominal/
Categorical

Demographic Prior PrEP
Experience

Nominal/
Categorical

Nominal/
Categorical
Nominal/
Categorical
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PrEP to a
Patient?
Before today,
how would
you rate your
knowledge of
PrEP’s
potential side
effects?
PrEP clinical
practice
knowledge
composite
measured at pre,
post and 30-day
follow-up

Demographi Provider
c
knowledge of
PrEP’s potential
side effects

Dependent

Comfort
identifying
PrEP eligible
patients
composite
score measured
at pre, post and
30-day follow-up
Confidence
prescribing
PrEP
composite
score measured
at pre, post and
30-day follow-up

Dependent

NP likelihood
to prescribe
PrEP in 6 months
measured at
pre & post
Intervention and
30-day follow-up

Dependent

Dependent
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Likert scale”

Categorical

1=Poor
2=Fair
3=Good
4=Very good
5=Excellent

Total score for all Numerical scale &
knowledge
ratio
construct questions The sum of the
number of correct
answers on 7
multiple choice
items and 3 rating
questions
measuring
knowledge
Total possible
score of 19.
Total score for all The sum of the
comfort construct numeric self-rated
questions
answers on 4
question’s rating
comfort on a 4point Likert scale.
Total possible
score of 16.
Total score for all The sum of the
confidence
numeric self-rated
construct
answers on 8
questions.
questions rating
confidence on a 4point Likert scale.
Total possible
score of 32.
NP selfLikert Scale:
determined
1= Not at all
2= Slightly
likelihood to
3= Moderately
prescribe
4= Extremely

Ratio (%)
Continuous Scale
(raw score)

Ratio (%)
Continuous Scale
(raw score)

Ratio (%)
Continuous Scale
(raw score)

Ordinal
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Appendix L
Data Dictionary

Data Element

Data Label

Data Type

Definition/Purpose

Data Values & Coding

Participant Identifier

Token

Alpha-numeric

Alpha-numeric

Employment Status

Empstatus

Categorical

Gender

gender

Categorical

Age

age

NP Experience

NPexper

Numeric,
continuous
Numeric,
continuous

Race/Ethnicity

race

Categorical

nursing education lvl

nursingedlvl

Categorical

Ever heard of PrEP

EverPrEP

Categorial

Personal identifier – 6
digits in length
Descriptive Item:
What is your
employment status?
Descriptive Item: What
is your gender?
Descriptive Item:
What is your age?
Descriptive Item:
How many years of
experience do you have
as a Nurse Practitioner?
Descriptive Item:
What is your Race/
Ethnicity?
Descriptive Item:
What is your highest
degree of nursing
education?
Descriptive Item:
Before today, had you
heard of PrEP?

1, Full time; 2, Regular Part time; 3,
Casual/ Committed Part time; 4,
Management and/or education
1, female; 2, male
Actual numeric value
Actual numeric value

1, African American or Black;
2, Asian; 3, Hispanic or Latino; 4,
White/Non-Hispanic; 5, Other
1, MSN or master’s degree; 2,
DNP/doctorate

1, Yes; 2, No
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Ever been asked about
PrEP by a patient

askedabtprep

Categorical

Descriptive Item:
Have you ever been
asked about PrEP by a
patient?
Descriptive Item:
Have you ever initiated
a conversation about
PrEP with patient?

1, Yes; 2, No

Ever initiated PrEP
topic with a patient

initiateconv

Categorical

Ever prescribed
PrEP to a patient?

prescribePrEP

Categorical

Descriptive Item: Have
you ever prescribed
PrEP to a patient?
Descriptive Item:
Before today, how
would you rate your
knowledge of PrEP’s
potential side effects
(e.g. renal dysfunction)?

1. Yes; 2, No

PrEP side
effect
knowledge

SEknowl

Categorical

PreK1 FDA approved
PrEP

preK1

Categorical
Nominal

Presurvey Knowledge
item #1:
Which medication has
been FDA-approved for
PrEP use?

CorrectpreK1

Categorical
Nominal

preK2

Categorical
Nominal

Answer:
Tenofovir/
Emtricitabine (Truvada)
Presurvey Knowledge
item #2:
How often should
patients on PrEP be
followed up for
medication side effects

Maraviroc (Selzentry); Tenofovir;
Tenofovir/ Emtricitabine (Truvada);
Tenofovir/ Emtricitabine/ Efavirenz
(Atripla); Raltegravir + Emtracitabine
(Isentress + Emtriva); none approved;
not sure
1, correct response;
0, incorrect response

Correct preK1 answer

PreK2 PrEP follow-up
frequency

1, Yes; 2, No

1, Excellent; 2, Very good; 3, Good; 4,
Fair; 5, Poor

Every month; Every 6 months; Every
3 months; Yearly; Not necessary after
first year
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and lab work-up after
the initial assessment?

Correct preK2 answer

CorrectpreK2

Categorical
Nominal

Answer:
Every 3 months

1, correct response;
0, incorrect response

PreK3 Clinical
eligibility does not
support initiation of
PrEP

preK3

Categorical
Nominal

Correct preK3 answer

CorrectpreK3

Categorical
Nominal

1, HIV negative status, no active
signs/ symptoms of HIV infection.
Positive HBsAg, GFR>60 ; 2, HIV
negative status, negative Anti-HBS,
Negative Hep C antibody, GFR<60;
3, HIV negative status, no active
signs/ symptoms of HIV infection,
GFR>60; 4, HIV negative status,
Negative HBsAg, no fever, fatigue,
pharyngitis,rash, night sweats and
adenopathy
1, correct response;
0, incorrect response

PreK 4PrEP post
HIVexposure

preK4

Categorical
Nominal

Presurvey Knowledge
item #3:
You are assessing recent
lab results for a 30-yearold male patient with
significant risk for HIV.
Which set of clinical
eligibility factors does
not support the
initiation of PrEP
(Truvada) at this time?
Answer:
HIV negative
status,negative
Anti-HBS, Negative
Hep C antibody,
GR<60
Presurvey Knowledge
item #4:
Can an individual be
initiated on PrEP after
becoming exposed to
HIV?

Correct preK4 answer

CorrectpreK4

Categorical
Nominal

Answer:
No. PrEP must
be initiated for
HIV

1, Yes. PrEP can be initiated within
72hours of becoming exposed to
HIV; 2, No. PrEP must be initiated for
HIV negative individuals only, 3,
Yes. PrEP can be taken for up to 7
days; 4, Only
Descovy can be started under this
circumstance
1, correct response;
0, incorrect response
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PreK5 Serious SE
of PrEP

preK5

Categorical
Nominal

Correct preK5 answer

CorrectpreK5

Categorical
Nominal

PreK6 Effectiveness
of PrEP

preK6

Categorical
Ordinal

Correct preK6 answer

CorrectpreK6

PreK7 PrEP safety

preK7

Categorical
Nominal
Categorical
Ordinal

Correct preK7 answer

CorrectpreK7

PreK8 Maximum
protection from anal
sex

preK8

Categorical
Nominal
Categorical
Nominal

negative individuals
only
Presurvey Knowledge
item #5:
What are the serious
side effects of PrEP?
Answer:
New or worsening renal
impairment, including
kidney failure
Presurvey Knowledge
item #6:
How effective do you
think PrEP is in
preventing acquisition
of HIV among people
who take it every day as
prescribed?
Answer:
4= Extremely Effective
Presurvey Knowledge
item #7:
Based on your
understanding of PrEP
side effects, how safe is
PrEP?
Answer:
4=Extremely safe
Presurvey Knowledge
item #8:

1, Increased bone mineral density; 2,
Increased buildup of calcium
deposits; 3, mild nausea and diarrhea;
4, New or worsening renal
impairment, including kidney failure
1, correct response;
0, incorrect response

1, Not at all effective; 2, Slightly
effective; 3, Moderately effective; 4,
Extremely effective

1, correct response;
0, incorrect response
1, Not at all safe; 2, Slightly safe;
3, Moderately safe; 4, Extremely
safe

1, correct response;
0, incorrect response
1, 3 days of daily use; 2, 4 days of
daily use; 3, 6 days of daily use; 4,
7days of daily use
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Correct preK8 answer

CorrectpreK8

PreK9
Maximum
protection from
vaginal sex

preK9

Correct preK9 answer

CorrectpreK9

PreK10 Importance of
condom use with PrEP

preK10

Correct PreK answer

CorrectpreK10

Total PreK score

PreK score
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Categorical
Nominal
Categorical
Nominal

Categorical
Nominal
Categorical
Ordinal

Categorical
Nominal
Numerical
Discrete

PrEP reaches maximum
protection from HIV for
receptive anal sex at
about how many days of
daily use?
Answer:
7 days of daily use
Presurvey Knowledge
item #9:
For receptive vaginal
sex and injection drug
use, PrEP reaches
maximum protection at
about how many days
of daily use?
Answer:
21 days of daily use
Presurvey Knowledge
item #10:
If a patient says he/she
is using condoms
consistently and
correctly, how important
is it to offer PrEP in
addition to condoms if
you have identified the
individual as possessing
high at-risk HIV?
Answer:
4=Extremely important
Total number of correct
responses

1, correct response;
0, incorrect response
1, 7 days of daily use; 2, 14 days of
daily use; 3, 21 days of daily use; 4,
28 days of daily use

1, correct response;
0, incorrect response
1, Not at all important; 2, Slightly
important; 3, Moderately important;
4, Extremely important

1, correct response;
0, incorrect response
Each point for each of the correct
responses for total of 10 points
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Pre Comfort with
evaluation for women
having sex with men

preComf1

Categorical
Ordinal

Presurvey Comfort item
#1:
How comfortable are
you evaluating PrEP
eligibility for Women
who have sex with
men?
Presurvey Comfort item
#2:
How comfortable are
you evaluating PrEP
eligibility for Men who
have sex with women
Presurvey Comfort item
#3:
How comfortable are
you evaluating PrEP
eligibility for Men who
have sex with men?

1, not at all comfortable; 2, slightly
comfortable; 3, moderately
comfortable; 4, extremely
comfortable

Pre Comfort with
evaluation for men
having sex with
women

preComf2

Categorical
Ordinal

Pre Comfort with
evaluation for men
having sex with men

preComf3

Categorical
Ordinal

Pre Comfort with
evaluation for people
who inject drugs

preComf4

Categorical
Ordinal

Presurvey Comfort item
#4:
How comfortable are
you evaluating PrEP
eligibility for People
who inject drugs?

1, not at all comfortable; 2, slightly
comfortable; 3, moderately
comfortable; 4, extremely
comfortable

Pre Comfort Score

PreComfscore

Numerical
Discrete

Total cumulative score
for Comfort related
questions

Total possible points from 4 to 16
numeric points

1, not at all comfortable; 2, slightly
comfortable; 3, moderately
comfortable; 4, extremely
comfortable

1, not at all comfortable; 2, slightly
comfortable; 3, moderately
comfortable; 4, extremely
comfortable
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Pre Confidence to
prescribe PrEP to a
female who has HIV
positive male partner

preCon1

Categorical
Ordinal

Presurvey Confidence
item #1:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a
female with a current
male partner known to
be HIV-positive?

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident

Pre Confidence to
prescribe PrEP to a
female who has sex
with unknown HIV
status male partners

preCon2

Categorical
Ordinal

Presurvey Confidence
item #2:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a
female who has
unprotected sex with
male partners with
unknown HIV status
who are at high risk of
HIV infection (e.g.
partners(s) who has sex
with other males or uses
injection drugs)?

1, not at all; 2, slightly confident; 3,
moderately confident; 4, extremely
confident

Pre Confidence to
prescribe PrEP to a
male with a current

preCon3

Categorical
Ordinal

Presurvey Confidence
item #3:

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident
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HIV positive
female partner

Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a male
with a current female
partner known to be
HIV-positive?

Pre Confidence to
prescribe PrEP to a
male who has
unprotected sex with
male partners with
unknown HIV status

preCon4

Categorical
Ordinal

Presurvey Confidence
item #4:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to A
male who has
unprotected sex with
male partners with
unknown HIV status
who are at high risk of
HIV infection (e.g.,
partner(s) who has sex
with other males or uses
injection drugs)?

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident

Pre Confidence to
prescribe PrEP to a
male with a current
HIV positive
male partner

preCon5

Categorical
Ordinal

Presurvey Confidence
item #5:
Assuming a recent
negative HIV test and
equal access to

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident
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medication, how
confident are you to
prescribe PrEP to a male
with a current male
partner known to be
HIV-positive?

Pre Confidence to
prescribe PrEP to a
male who has sex with
multiple male partners
and has had
unprotected anal sex

preCon6

Categorical
Ordinal

Presurvey Confidence
1, not at all confident; 2, slightly
item #6:
confident; 3, moderately confident; 4,
Assuming a recent
extremely confident
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a male
who has sex with
multiple male partners
and has had unprotected
anal sex?

Pre Confidence to
prescribe PrEP to a
person who has
injected drugs in the
past 6 months and
shared injection
equipment

preCon7

Categorical
Ordinal

Presurvey Confidence
item #7:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a
person who has injected
drugs in the past 6
months and shared
injection equipment?

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident
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Pre Confidence to
prescribe PrEP to a
person who has been
on methadone
maintenance for the
past 6 months but has
continued injection
drug use

preCon8

Categorical
Ordinal

Presurvey Confidence
item #8:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a
person who has been on
methadone maintenance
for the past 6 months
but has continued
injection drug use?

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident

Pre Confidence total
score

PreConScore

Numerical
Discrete

Total possible points 8 to 32 numeric
points

Pre-Likeliness to
prescribe PrEP in
next 6 months

Pre_prescribe

Ordinal

PostK1 FDA approved
PrEP

postK1

Categorical
Nominal

Total score of all pre
Confidence related
responses
Presurvey item: How
likely are you to
prescribe PrEP in the
next 6 months?
Postsurvey Knowledge
item #1:
Which medication has
been FDA-approved for
PrEP use?

Correct postK1 answer

CorrectpostK1

Categorical
Nominal

Answer:
Tenofovir/
Emtricitabine (Truvada)

1, not at all; 2, slightly; 3, moderately;
4, extremely

1, Maraviroc (Selzentry); 2,
Tenofovir; 3, Tenofovir/ Emtricitabine
(Truvada); 4, Tenofovir/
Emtricitabine/ Efavirenz (Atripla); 5,
Raltegravir + Emtracitabine (Isentress
+ Emtriva) 6, none approved; 7, not
sure
1, correct response;
0, incorrect response
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PostK2 PrEP followup frequency

postK2

Categorical
Nominal

Correct postK2 answer

CorrectpostK2

Categorical
Nominal

PostK3 Clinical
eligibility does not
supportinitiation of
PrEP

postK3

Categorical
Nominal

Correct postK3 answer

CorrectpostK3

Categorical
Nominal

PostK4 PrEP post
HIVexposure

postK4

Categorical
Nominal

Postsurvey Knowledge
item #2:
How often should
patients on PrEP be
followed up for
medication side effects
and lab work-up after
the initial assessment?
Answer:
Every 3 months

1, Every month; 2, Every 6 months, 3,
Every 3 months, 4, Yearly, 5, Not
necessary after first year

Postsurvey Knowledge
item #3:
You are assessing recent
lab results for a 30-yearold male patient with
significant risk for HIV.
Which set of clinical
eligibility factors does
not support the
initiation of PrEP
(Truvada) at this time?
Answer:
HIV negative
status,negative
Anti-HBS,
Negative Hep C
antibody,
GR<60
Postsurvey Knowledge
item #4:
Can an individual be
initiated on PrEP after
becoming exposed to
HIV?

1, HIV negative status, no active
signs/ symptoms of HIV infection.
Positive HBsAg, GFR>60 ; 2, HIV
negative status, negative Anti-HBS,
Negative Hep C antibody, GFR<60;
3, HIV negative status, no active
signs/ symptoms of HIV infection,
GFR>60; 4, HIV negative status,
Negative HBsAg, no fever, fatigue,
pharyngitis,rash, night sweats and
adenopathy
1, correct response;
0, incorrect response

1, correct response;
0, incorrect response

1, Yes. PrEP can be initiated within
72hours of becoming exposed to
HIV; 2, No. PrEP must be initiated for
HIV negative individuals only, 3,
Yes. PrEP can be taken for up to 7
days; 4, Only
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Correct postK4 answer

CorrectpostK4

Categorical
Nominal

PostK5 Serious SE
of PrEP

postK5

Categorical
Nominal

Correct postK5 answer

CorrectpostK5

Categorical
Nominal

PostK6Effectiveness
of PrEP

postK6

Categorical
Ordinal

Correct postK6 answer

CorrectpostK6

PostK7PrEP safety

postK7

Categorical
Nominal
Categorical
Ordinal

Answer:
No. PrEP must be
initiated for HIV
negative individuals
only
Postsurvey Knowledge
item #5:
What are the serious
side effects of PrEP?
Answer:
New or worsening renal
impairment, including
kidney failure
Postsurvey Knowledge
item #6:
How effective do you
think PrEP is in
preventing acquisition
of HIV among people
who take it every day as
prescribed?
Answer:
4= Extremely Effective
Postsurvey knowledge
item #7:
Based on your
understanding of PrEP
side effects, how safe is
PrEP?

Descovy can be started under this
circumstance
1, correct response;
0, incorrect response

1, Increased bone mineral density; 2,
Increased buildup of calcium
deposits; 3, mild nausea and diarrhea;
4, New or worsening renal
impairment, including kidney failure
1, correct response;
0, incorrect response

1, Not at all effective; 2, Slightly
effective; 3, Moderately effective; 4,
Extremely effective

1, correct response;
0, incorrect response
1, Not at all safe; 2, Slightly safe;
3, Moderately safe; 4, Extremely
safe
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CorrectpostK7

PostK8Maximum
protection from anal
sex

postK8

Correct postK8 answer

CorrectpostK8

PostK9Maximu
m protection
from vaginal sex

postK9

Correct postK9 answer

CorrectpostK9

PostK10Importance of
condom use with PrEP

postK10
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Categorical
Nominal
Categorical
Nominal

Categorical
Nominal
Categorical
Nominal

Categorical
Nominal
Categorical
Ordinal

Answer:
4=Extremely safe
Postsurvey Knowledge
item #8:
PrEP reaches maximum
protection from HIV for
receptive anal sex at
about how many days of
daily use?
Answer:
7 days of daily use
Postsurvey Knowledge
item #9:
For receptive vaginal
sex and injection drug
use, PrEP reaches
maximum protection at
about how many days
of daily use?

1, correct response;
0, incorrect response
1, 3 days of daily use; 2, 4 days of
daily use; 3, 6 days of daily use; 4,
7days of daily use

Answer:
21 days of daily use
Postsurvey Knowledge
item #10:
If a patient says he/she
is using condoms
consistently and
correctly, how important
is it to offer PrEP in
addition to condoms if
you have identified the
individual as possessing
high at-risk HIV?

1, correct response;
0, incorrect response
1, Not at all important; 2, Slightly
important; 3, Moderately important;
4, Extremely important

1, correct response;
0, incorrect response
1, 7 days of daily use; 2, 14 days of
daily use; 3, 21 days of daily use; 4,
28 days of daily use
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Correct postK answer
Total post Kscore
Post Comfort with
evaluation for women
having sex with men
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CorrectpostK10 Categorical
Nominal
Numerical
PostKscore
Discrete
postComf1
Categorical
Ordinal

Post Comfort with
evaluation for men
having sex with
women

postComf2

Categorical
Ordinal

Post Comfort with
evaluation for men
having sex with men

postComf3

Categorical
Ordinal

Post Comfort with
evaluation for people
who inject drugs

postComf4

Categorical
Ordinal

Answer:
4=Extremely important
Total number of correct
responses
Postsurvey Comfort
item #1:
How comfortable are
you evaluating PrEP
eligibility for Women
who have sex with
men?
Postsurvey Comfort
item #2:
How comfortable are
you evaluating PrEP
eligibility for Men who
have sex with women?
Postsurvey Comfort
item #3:
How comfortable are
you evaluating PrEP
eligibility for Men who
have sex with men?

1, correct response;
0, incorrect response
Each point for each of the correct
responses for total of 10 points
1, not at all comfortable; 2, slightly
comfortable; 3, moderately
comfortable; 4, extremely
comfortable

Postsurvey Comfort
item #4:
How comfortable are
you evaluating PrEP
eligibility for People
who inject drugs?

1, not at all comfortable; 2, slightly
comfortable; 3, moderately
comfortable; 4, extremely
comfortable

1, not at all comfortable; 2, slightly
comfortable; 3, moderately
comfortable; 4, extremely
comfortable

1, not at all comfortable; 2, slightly
comfortable; 3, moderately
comfortable; 4, extremely
comfortable
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Post Comf Score

PostComfscore

Numerical
Discrete

Post Confidence to
prescribe PrEP to a
female who has HIV
positive male partner

postCon1

Categorical
Ordinal

Post Confidence to
prescribe PrEP to a
female who has sex
with unknown HIV
status male partners

postCon2

Categorical
Ordinal

Total cumulative score
for Comfort related
questions
Postsurvey Confidence
item #1:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a
female with a current
male partner known to
be HIV-positive?

Total possible points from 4 to 16
numeric points

Postsurvey Confidence
item #2:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a
female who has
unprotected sex with
male partners with
unknown HIV status
who are at high risk of
HIV infection (e.g.
partners(s) who has sex
with other males or uses
injection drugs)?

1, not at all; 2, slightly confident; 3,
moderately confident; 4, extremely
confident

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident
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Post Confidence to
prescribe PrEP to a
male with a current
HIV
positive
female partner

postCon3

Categorical
Ordinal

Postsurvey Confidence
1, not at all confident; 2, slightly
item #3:
confident; 3, moderately confident; 4,
extremely confident
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a male
with a current female
partner known to be
HIV-positive?

Post Confidence to
prescribe PrEP to a
male who has
unprotected sex with
male partners with
unknown HIV status

postCon4

Categorical
Ordinal

Postsurvey Confidence
item #4:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to A
male who has
unprotected sex with
male partners with
unknown HIV status
who are at high risk of
HIV infection (e.g.,
partner(s) who has sex
with other males or uses
injection drugs)?

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident

Post Confidence to
prescribe PrEP to a
male with a current

postCon5

Categorical
Ordinal

Postsurvey Confidence
item #5:

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident
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HIV positive
male partner

Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a male
with a current male
partner known to be
HIV-positive?

Post Confidence to
prescribe PrEP to a
male who has sex with
multiple male partners
and has had
unprotected anal sex

postCon6

Categorical
Ordinal

Postsurvey Confidence
1, not at all confident; 2, slightly
item #6:
confident; 3, moderately confident; 4,
Assuming a recent
extremely confident
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a male
who has sex with
multiple male partners
and has had unprotected
anal sex?

Post Confidence to
prescribe PrEP to a
person who has
injected drugs in the
past 6 months and
shared injection
equipment

postCon7

Categorical
Ordinal

Postsurvey Confidence
item #7:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a
person who has injected
drugs in the past 6

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident
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months and shared
injection equipment?

Post Confidence to
prescribe PrEP to a
person who has been
on methadone
maintenance for the
past 6 months but has
continued injection
drug use

postCon8

Categorical
Ordinal

Postsurvey Confidence
item #8:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a
person who has been on
methadone maintenance
for the past 6 months
but has continued
injection drug use?

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident

Post Confidence total
score

PostConScore

Numerical
Discrete

Total possible points 8 to 32 numeric
points

Post-Likeliness to
prescribe PrEP in
next 6 months

Post prescribe

Ordinal

ReK1 FDA approved
PrEP

ReK1

Categorical
Nominal

Total score of all post
Confidence related
responses
Postsurvey item: How
likely are you to
prescribe PrEP in the
next 6 months?
Retention Knowledge
item #1:
Which medication has
been FDA-approved for
PrEP use?

1, not at all; 2, slightly; 3, moderately;
4, extremely

1, Maraviroc (Selzentry); 2,
Tenofovir; 3, Tenofovir/ Emtricitabine
(Truvada); 4, Tenofovir/
Emtricitabine/ Efavirenz (Atripla); 5,
Raltegravir + Emtracitabine (Isentress
+ Emtriva) 6, none approved; 7, not
sure
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Correct ReK1 answer

CorrectReK1

Categorical
Nominal

ReK2 PrEP follow-up
frequency

ReK2

Categorical
Nominal

Correct ReK2 answer

CorrectReK2

Categorical
Nominal

ReK3 Clinical
eligibilitynot support
initiation of PrEP

ReK3

Categorical
Nominal

Correct ReK3 answer

CorrectReK3

Categorical
Nominal

ReK 4PrEP post HIV
exposure

ReK4

Categorical
Nominal

Answer:
Tenofovir/
Emtricitabine (Truvada)
Retention Knowledge
item #2:
How often should
patients on PrEP be
followed up for
medication side effects
and lab work-up after
the initial assessment?
Answer:
Every 3 months

1, correct response;
0, incorrect response

Retention Knowledge
item #3:
You are assessing recent
lab results for a 30-yearold male patient with
significant risk for HIV.
Which set of clinical
eligibility factors does
not support the
initiation of PrEP
(Truvada) at this time?
Answer:
HIV negative
status,negative
Anti-HBS, Negative
Hep C antibody,
GR<60
Retention Knowledge
item #4:

1, HIV negative status, no active
signs/ symptoms of HIV infection.
Positive HBsAg, GFR>60 ; 2, HIV
negative status, negative Anti-HBS,
Negative Hep C antibody, GFR<60;
3, HIV negative status, no active
signs/ symptoms of HIV infection,
GFR>60; 4, HIV negative status,
Negative HBsAg, no fever, fatigue,
pharyngitis,rash, night sweats and
adenopathy
1, correct response;
0, incorrect response

1, Every month; 2, Every 6 months, 3,
Every 3 months, 4, Yearly, 5, Not
necessary after first year

1, correct response;
0, incorrect response

1, Yes. PrEP can be initiated within 72
hours of becoming exposed to HIV; 2,
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Can an individual be
initiated on PrEP after
becoming exposed to
HIV?

Correct ReK4 answer

CorrectReK4

Categorical
Nominal

ReK5 Serious SE
of PrEP

ReK5

Categorical
Nominal

Correct ReK5 answer

CorrectReK5

Categorical
Nominal

ReK6 Effectiveness
of PrEP

ReK6

Categorical
Ordinal

Correct ReK6 answer

CorrectReK6

ReK7 PrEP safety

ReK7

Categorical
Nominal
Categorical
Ordinal

Answer:
No. PrEP must be
initiated for HIV
negative individuals
only
Retention Knowledge
item #5:
What are the serious
side effects of PrEP?
Answer:
New or worsening renal
impairment, including
kidney failure
Retention Knowledge
item #6:
How effective do you
think PrEP is in
preventing acquisition
of HIV among people
who take it every day as
prescribed?
Answer:
4= Extremely Effective
Retention Knowledge
item #7:

No. PrEP must be initiated for HIV
negative individuals only, 3, Yes.
PrEP can be taken for up to 7 days; 4,
Only Descovy can be started under
this
circumstance
1, correct response;
0, incorrect response

1, Increased bone mineral density; 2,
Increased buildup of calcium
deposits; 3, mild nausea and diarrhea;
4, New or worsening renal
impairment, including kidney failure
1, correct response;
0, incorrect response

1, Not at all effective; 2, Slightly
effective; 3, Moderately effective; 4,
Extremely effective

1, correct response;
0, incorrect response
1, Not at all safe; 2, Slightly safe; 3,
Moderately safe; 4, Extremely safe

THE PREP EDUCATION INTERVENTION

Correct ReK7 answer

CorrectReK7

ReK8 Maximum
protection from anal
sex

ReK8

Correct ReK8 answer

CorrectReK8

ReK9
Maximum
protection from
vaginal sex

ReK9

Correct ReK9 answer

CorrectReK9

ReK10 Importance of
condom use with PrEP

ReK10
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Categorical
Nominal
Categorical
Nominal

Categorical
Nominal
Categorical
Nominal

Categorical
Nominal
Categorical
Ordinal

Based on your
understanding of PrEP
side effects, how safe is
PrEP?
Answer:
4=Extremely safe
Retention Knowledge
item #8:
PrEP reaches maximum
protection from HIV for
receptive anal sex at
about how many days of
daily use?
Answer:
7 days of daily use
Retention Knowledge
item #9:
For receptive vaginal
sex and injection drug
use, PrEP reaches
maximum protection at
about how many days
of daily use?
Answer:
21 days of daily use
Retention Knowledge
item #10:
If a patient says he/she
is using condoms
consistently and
correctly, how important
is it to offer PrEP in

1, correct response;
0, incorrect response
1, 3 days of daily use; 2, 4 days of
daily use; 3, 6 days of daily use; 4,
7days of daily use

1, correct response;
0, incorrect response
1, 7 days of daily use; 2, 14 days of
daily use; 3, 21 days of daily use; 4,
28 days of daily use

1, correct response;
0, incorrect response
1, Not at all important; 2, Slightly
important; 3, Moderately important;
4, Extremely important
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Correct ReK answer

CorrectReK10

Total Retention Kscore

ReKscore

Retention Comfort
with evaluation for
women having sex
with men

reComf1

Retention Comfort
with evaluation for
men having sex with
women

reComf2

Categorical
Ordinal

Retention Comfort
with evaluation for
men having sex with
men

reComf3

Categorical
Ordinal

Retention Comfort
with evaluation for
people who inject
drugs

reComf4

Categorical
Ordinal

Categorical
Nominal
Numerical
Discrete
Categorical
Ordinal

addition to condoms if
you have identified the
individual as possessing
high at-risk HIV?
Answer:
4=Extremely important
Total number of correct
responses
Retention Comfort item
#1:
How comfortable are
you evaluating PrEP
eligibility for Women
who have sex with
men?
Retention Comfort item
#2:
How comfortable are
you evaluating PrEP
eligibility for Men who
have sex with women
Retention Comfort item
#3:
How comfortable are
you evaluating PrEP
eligibility for Men who
have sex with men?
Retention Comfort item
#4:
How comfortable are
you evaluating PrEP

1, correct response;
0, incorrect response
Each point for each of the correct
responses for total of 10 points
1, not at all comfortable; 2, slightly
comfortable; 3, moderately
comfortable; 4, extremely
comfortable

1, not at all comfortable; 2, slightly
comfortable; 3, moderately
comfortable; 4, extremely
comfortable

1, not at all comfortable; 2, slightly
comfortable; 3, moderately
comfortable; 4, extremely
comfortable

1, not at all comfortable; 2, slightly
comfortable; 3, moderately
comfortable; 4, extremely
comfortable
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eligibility for People
who inject drugs:

Retention Comf Score

ReComfscore

Numerical
Discrete

Retention Confidence
to prescribe PrEP to a
female who has HIV
positive male partner

reCon1

Categorical
Ordinal

Retention Confidence
to prescribe PrEP to a
female who has sex
with unknown HIV
status male partners

reCon2

Categorical
Ordinal

Total cumulative score
for Comfort related
questions
Retention Confidence
item #1:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a
female with a current
male partner known to
be HIV-positive?

Total possible points from 4 to 16
numeric points

Retention Confidence
item #2:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a
female who has
unprotected sex with
male partners with
unknown HIV status
who are at high risk of
HIV infection (e.g.
partners(s) who has sex

1, not at all; 2, slightly confident; 3,
moderately confident; 4, extremely
confident

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident
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with other males or uses
injection drugs)?

Retention Confidence
to prescribe PrEP to a
male with a current
HIV positive female
partner

reCon3

Categorical
Ordinal

Retention Confidence
1, not at all confident; 2, slightly
item #3:
confident; 3, moderately confident; 4,
extremely confident
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a male
with a current female
partner known to be
HIV-positive?

Retention Confidence
to prescribe PrEP to a
male who has
unprotected sex with
male partners with
unknown HIV status

reCon4

Categorical
Ordinal

Retention Confidence
item #4:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to A
male who has
unprotected sex with
male partners with
unknown HIV status
who are at high risk of
HIV infection (e.g.,
partner(s) who has sex
with other males or uses
injection drugs)?

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident
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Retention Confidence
to prescribe PrEP to a
male with a current
HIV positive male
partner

reCon5

Categorical
Ordinal

Retention Confidence
1, not at all confident; 2, slightly
item #5:
confident; 3, moderately confident; 4,
extremely confident
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a male
with a current male
partner known to be
HIV-positive?

Retention Confidence
to prescribe PrEP to a
male who has sex with
multiple male partners
and has had
unprotected anal sex

reCon6

Categorical
Ordinal

Retention Confidence
1, not at all confident; 2, slightly
item #6:
confident; 3, moderately confident; 4,
Assuming a recent
extremely confident
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a male
who has sex with
multiple male partners
and has had unprotected
anal sex?

Retention Confidence
to prescribe PrEP to a
person who has
injected drugs in the
past 6 months and
shared injection
equipment

reCon7

Categorical
Ordinal

Posttest Confidence
item #7:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident
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person who has injected
drugs in the past 6
months and shared
injection equipment?

Retention Confidence
to prescribe PrEP to a
person who has been
on methadone
maintenance for the
past 6 months but has
continued injection
drug use

reCon8

Categorical
Ordinal

Posttest Confidence
item #8:
Assuming a recent
negative HIV test and
equal access to
medication, how
confident are you to
prescribe PrEP to a
person who has been on
methadone maintenance
for the past 6 months
but has continued
injection drug use?

1, not at all confident; 2, slightly
confident; 3, moderately confident; 4,
extremely confident

Retention Confidence
total score

ReConScore

Numerical
Discrete

Total possible points 8 to 32 numeric
points

Retention surveyLikeliness to prescribe
PrEP in next 6 months

Re_prescribe

Ordinal

Total score of all post
Confidence related
responses
Retention survey item:
How likely are you to
prescribe PrEP in the
next 6 months?

1, not at all; 2, slightly; 3, moderately;
4, extremely
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Appendix M
Budget Table
Table 3. PrEP Education Intervention’s Budget
Necessary Items

Item Cost

Total Cost $

Survey Collection Platform

$276 – annual subscription

$276

Subject Incentive (Target)

$20 – each gift card X 5

$100

Articulate 360 subscription

$500

$500

$99

$ 99

(e-learning platform)
SPSS 27 subscription

$975
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Appendix N
Participant Characteristics and Prior Experiences
Table 4. Sociodemographic Characteristics of Participants at Baseline
Participants
Employment status
Full Time
Regular Part Time
Casual/Committed Part
Time
Gender
Male
Female
Race
African American or Black
Asian
Hispanic or Latino
White/ Non-Hispanic
Other
Nursing Education Level
MSN or master’s degree
DNP/ Doctorate
Age
Years’ Experience
1
Five subjects missing data

n (%)
39 (100)
34 (87.2)
1 (2.6)
3 (7.7)
1 (2.6)
1 (2.6)
38 (97.4)
11 (28.2)
10 (25.6)
1 (2.6)
14 (35.9)
3 (7.7)
30 (76.9)
9 (23.7)
M (SD)
38.79 (8.89) 1
6.35 (8.98)

Note. This table depicts demographics for all 39 participants of the PrEP education intervention.
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Table 5. Prior Experiences with PrEP
Items
Heard about PrEP?
Yes
No
Ever asked a Patient about PrEP?
Yes
No
Ever initiated a patient conversation about PrEP?
Yes
No
Ever prescribed PrEP?1
Yes
No
Before today, how would you rate your knowledge of
PrEP’s potential side effects?
Excellent

Very Good
Good
Fair
Poor
1
Does not equal 100% due to missing data

n (%)
38 (97.4)
1 (2.6)
25 (65.8)
14 (35.9)
19 (48.7)
20 (51.3)
20 (51.3)
18 (46.2)
0 (0%)
3 (7.9)
14 (36.8)
14 (36.8)
7 (18.4)

Note. Participants’ prior experiences with PrEP are being described in percentages. The
knowledge rating question regarding his or her knowledge of PrEP was based on a 5-point Likert
Scale. Percentage breakdowns highlight that less than 50% of participants had baseline rating of
“Good” or “Very Good” prior to the education tutorial.

THE PREP EDUCATION INTERVENTION

113

Appendix O
Paired t-Test
Table 6. Paired t-Tests for Pre and Post Survey Results
Post

Pre

M

SD

n

M

Knowledge

8.10

1.651

39

6.44

Comfort

11.74

3.142

38

9.97

Confidence 24.18

5.703

39

N

95% CI
Lower Upper

t

df

p

1.373 39

5.159

38

<.001

1.013

2.321

3.412 38

2.827

37

.008

.500

3.027

19.54 6.786 39

4.516

38

<.001

2.561

6.721

SD

Note. This table demonstrates the mean scores for all constructs for the pre- and post-survey
items. There were significant mean differences between pre-survey scores compared with postsurvey scores for all constructs. The mean scores for the construct that explored comfort
identifying “at-risk HIV individuals” was also found to be significant.
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Appendix P
Knowledge Mean Scores
Figure 3. Mean Scores for Knowledge about PrEP’s Clinical Practice
10.00

8.13

Estimated Marginal Means

8.00

7.19

6.23
6.00

4.00

2.00

0.00
Pre

Post

ReTest

Knowledge (.95 CI)

Note. This figure depicts the mean score differences across the three survey phases for the
knowledge about PrEP clinical practice. Each survey’s total possible knowledge score was 10
points for the ten PrEP related knowledge questions.
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Appendix Q
Knowledge Mean, SD, and ANOVA
Table 7. Mean and SD for Knowledge of PrEP Clinical Practice
Knowledge of PrEP clinical practice
M
SD
N
PreKscore
6.23
1.359
31
PostKscore
8.13
1.648
31
ReKscore
7.19
1.778
31
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Table 8. Repeated measures ANOVA – Knowledge of PrEP Clinical Practice

Overall

Knowledge

Sum Squares

Df

56.151

2

Mean
Difference

Pre vs Post
-1.903*
Pre vs Retention
-.968*
Post vs Retention
.939*
*p ≤ 0.05, a Bonferroni post-hoc

Mean
Square
28.075

a

Std. Error

Sig.

.366
.333
.385

<.001
.020
.064

p

F

<.001

13.825

P
Eta2
.315

95% Confidence Interval
for Difference a
Lower
Upper
-2.83
-.975
-1.81
-.124
-.041
1.912

Note. This table demonstrates the pairwise mean differences for the repeated measures of the
knowledge construct’s total composite scores. The average mean score for 31 participants for
each survey was analyzed. The postKscore and preKscore mean differences were significantly
different. The ReKscore was also significantly different from the PreKscore. There was no
significant difference between the ReKscore and PostKscore.
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Appendix R
Comfort Mean Scores
Figure 4. Mean Scores for Comfort Identifying “At-Risk HIV Patients”
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Note. This figure depicts the difference in mean rating scores across the three survey points for
the comfort construct which measured the comfort level associated with identifying “at-risk
HIV” individuals. The survey consisted of 16 possible points for the four items related to
comfort identifying “at-risk HIV patients.”

THE PREP EDUCATION INTERVENTION
Appendix S
Comfort Mean, SD, and ANOVA
Table 9. Mean and SD for Comfort Identifying “At-Risk HIV Patients”
Comfort Screening “At-risk HIV Patients”
M
SD
N
PreComfscore 10.00
3.572
30
PostComfscore 11.67
3.377
30
ReComfscore
12.50
1.961
30
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Table 10. Repeated measures ANOVA – Comfort Identifying “At-Risk HIV Patients”

Overall

Comfort

Sum
Squares
97.222

Mean
Difference

Pre vs Post
-1.667
Pre vs Retention
-2.500*
Post vs Retention
-.833
*p ≤ 0.05, a Bonferroni post-hoc

df
2

Std.
Error
.715
.612
.541

Mean
Square
48.611

Sig.a
.081
.001
.402

p

F

P Eta2

.001

8.257

222

95% Confidence Interval
for Difference
a

Lower
-3.483
-4.054
-2.207

Upper
.150
-.946
.540

Note. This table demonstrates the pairwise mean differences for the repeated measures of the
comfort construct’s total composite scores. The average score for the 30 participants were
analyzed for the three surveys. The means for PreComfscore and PostComfscore were not
significantly different. However, the mean score was significant when ReComfscore was
compared to the PreComfscore, PostComfscore, and ReComfscore were not significantly
different.
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Appendix T
Confidence Mean Scores
Figure 5. Mean Scores for Confidence to Prescribe PrEP
30.00
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Note. This figure depicts the difference in mean rating scores across the three survey points for
the confidence with PrEP prescribing practices. This construct consisted of eight questions with
a 4-point Likert Scale answers. There were 32 possible points for the eight items related to
confidence prescribing PrEP.
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Confidence Mean, SD, and ANOVA
Table 11. Mean and SD for Confidence to Prescribe PrEP
Confidence Prescribing PrEP
Std.
Mean Deviation
PreConScore
19.65
6.993
PostConScore 24.90
5.473
ReConScore
25.48
4.122

n
31
31
31
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Table 12. Repeated measures ANOVA – Confidence to Prescribe PrEP

Overall

Confidence

Mean
Square
320.720

Sum Squares

Df

641.441

2

Mean
Difference

Std.
Error

Sig.

.986
1.53
.796

.001
.001
.999

Pre vs Post
-5.258*
Pre vs Retention
-5.839*
Post vs Retention
-.581
a
*p ≤ 0.05, Bonferroni post-hoc

a

p

F

P Eta2

<.001

21.149

.413

95% Confidence Interval
for Difference a
Lower
Upper
-7.758
-2.758
-8.762
-2915
-2.600
1.438

Note. This table demonstrates the pairwise mean differences for the repeated measures of the
confidence construct’s total composite scores. Significant mean differences with p<.05 are
notable between PreConScore and PostConScore as well PreConScore and ReConScore. There
was no significant mean difference between PostConScore and ReConScore.
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Appendix V
All Constructs Mean Scores
Figure 6. Mean Scores Across All Constructs
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Note. This figure represents the mean ratings that was notable for the presurvey, postsurvey and
retention survey results. The mean scores for PrEP clinical practice knowledge, comfort
identifying at-risk HIV patients, and confidence with PrEP prescribing practices are depicted at a
glance. These estimated marginal mean ratings were collected at .95 confidence interval.
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Appendix W

Likeliness to Prescribe
Figure 7. Likeliness to Prescribe PrEP in the Next Six Months
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Note. This figure demonstrates the mean rank for the question, “How likely are you to
prescribe PrEP in the next 6 months?” The mean ranking increased throughout the three
phases.
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Appendix X
Friedman’s ANOVA
Table 13. Pairwise Comparison for Friedman’s ANOVA
N
Friedman’s
Likeliness to
Prescribe in next Difference
six months
Pre vs Post
.650*
Pre vs Retention
.800*
Post vs Retention
-.150
a
*p ≤ 0.05, Bonferroni post-hoc

Χ2

df

30

22.448
2
Std. Test
Std.
Statistic
Error
.258
.258
.258

2.517
3.098
-.581

Asymptotic Sig.
(2-sided test)
<.0001
Sig.

Adj.
Siga

.012
.002
.561

.035
.006
.999

Note. This table demonstrates the changed likeliness to prescribe ratings for the three
surveys administered. The result indicated that likeliness to prescribe in next six months at
baseline pre-survey was significantly different from post-survey and pre-survey from
retention survey. However, likeliness to prescribe for retention survey was not significantly
different from post-survey.

